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The 6th International Conference on Emerging Zoonoses, held at Cancun, Mexico, 
February 24-27, 2011, offered 84 participants from 18 countries a snapshot of current 
research in numerous zoonoses caused by viruses, bacteria or prions. Co-chaired by 
Professors Heinz Feldmann and Jürgen Richt, the conference explored 10 topics: (1) 
The ecology of emerging zoonotic diseases; (2) The role of wildlife in emerging 
zoonoses; (3) Cross-species transmission of zoonotic pathogens;(4) Emerging and 
neglected influenza viruses; (5) Hemorrhagic fever viruses; (6) Emerging bacterial 
diseases; (7) Outbreak responses to zoonotic diseases; (8) Food-borne zoonotic 
diseases; (9) Prion diseases; and (10) Modeling and prediction of emergence of 
zoonoses. Human medicine, veterinary medicine and environmental challenges are 
viewed as a unity, which must be considered under the umbrella of ‘One Health’. 
Several presentations attempted to integrate the insights gained from field data with 
mathematical models in the search for effective control measures of specific zoonoses. 
The overriding objective of the research presentations was to create, improve and use 
the tools essential to address the risk of contagions in a globalized society. In seeking to 
fulfil this objective, a three-step approach has often been applied: (1) use cultured cells, 
model and natural animal hosts and human clinical models to study infection; (2) 
combine traditional histopathological and biochemical approaches with functional 
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genomics, proteomics and computational biology; and (3) obtain signatures of virulence 
and insights into mechanisms of host defense response, immune evasion and 
pathogenesis. This meeting review summarizes 39 of the conference presentations and 
mentions briefly the 16 articles in this Special Supplement, most of which were 
presented at the conference in earlier versions. The full affiliations of all presenters and 
many colleagues have been included to facilitate further inquiries from readers. 
   
1.  The Ecology of Emerging Zoonotic Diseases 
As new zoonotic diseases continually emerge, one learns to expect the unexpected. The 
emerging zoonotic disease situations considered during the opening day of the Cancun 
Conference were the West Nile Virus, Lyme disease, interactions among multiple tick-
borne pathogens, Hantaviruses in the context of rodent dynamics, the Usutu virus (a 
mosquito-borne flavivirus) and a novel astrovirus enterotoxin. Furthermore, the 
importance of systems and computational biology was stressed, whatever emerging 
disease was being investigated (Poland et al., 2011). In addition to the summaries below 
of six presentations on this topic, this Special Supplement includes an article, 
Monitoring of West Nile Virus Infections in Germany by Dr. U. Ziegler et al. which 
identified West Nile Virus (WNV) antibodies in migratory birds, but not in resident 
birds, domestic poultry or in local horse populations throughout Germany. The WNV 
antibody-positive species were found in birds that migrate to tropical Africa or southern 
Europe; however, WNV-specific RNA could not be found in any of the samples. 
 
The Conference opened with a presentation from Professor M. A. Diuk-Wasser and her 
colleagues J. Simpson and C. M. Fosom-O’Keefe (all Yale School of Public Health, 
New Haven, CT, USA) and G. Molei, P. M. Armstrong, and T. G. Andreadis (Center 
for Vector Biology and Zoonotic Species at the Connecticut Agricultural Experiment 
Station, New Haven, CT, USA), Ecology of West Nile Virus in the Northeastern 
United States. Professor Diuk-Wasser began by noting that West Nile Virus (WNV) 
was introduced into New York City in 1999 by unknown means and was now 
considered endemic throughout the USA, with 29,700 human cases and 1,180 deaths in 
the USA since 1999. It had been hypothesized that increased biodiversity leads to a 
decreased risk of exposure to zoonotic pathogens (Keesing, Holt and Ostfeld, 2006). At 
issue is whether this ‘dilution effect’ or ‘Zooprophylaxis’ for vector-borne pathogens 
applies only when vectors are generalist feeders, because the link between host diversity 
and pathogen transmission might break down when vectors exhibit host preferences.   
  In the northeastern United States, WNV perpetuates in an enzootic transmission 
cycle involving Culex spp. mosquitoes and virus-competent avian hosts. Previous 
studies had detected that a large proportion of C. pipiens and C. restuans bloodmeals 
were derived from American robins (Turdus migratorius), suggesting a key role for this 
bird species in the WNV transmission cycle (Molaei et al, 2006; Kilpatrick et al, 2006). 
The New Haven-based research team tested for preferential feeding by conducting equal 
choice experiments (robins vs. other bird species) (Simpson et al., 2009) and by 
comparing the proportion of Culex spp. bloodmeals acquired from robins to the 
proportion of robins in the local bird community. Both methods indicated preferential 
feeding for robins. They were also able to identify robin communal roosts as 
amplification foci in greater New Haven (Diuk-Wasser et al., 2010). Then, through 
field-informed mathematical modeling, they determined that host preferences were 
indeed key drivers of WNV transmission, and that landscape attributes (such as 
urbanization), in combination with mosquito abundance and a measure of host 
community competence were the strongest predictors of pathogen prevalence (Simpson 
et al., 2011). Thus it was clear that pathogen prevalence and human risk of infection 
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were best predicted by assessing the relative pathogen competence and attractiveness to 
vectors of all species in the host community, rather than using simple measures of 
biodiversity. 
 
In the next presentation, Interactions among Multiple Tick-borne Pathogens in a 
Natural Reservoir Host, Professor Fish and his colleagues J. Brown, M. Fitzpatrick, S. 
Usmani-Brown, P. Cislo and P. Krause (Yale School of Public Health, New Haven, CT, 
USA) stressed that species interactions within a parasite community drive infection risk 
in a wildlife population (Telfer et al., 2010). At least five tick-borne pathogens are 
known to be transmitted by Ixodes scapularis, the principal vector of Lyme disease in 
the United States: (1) Borrelia burgdorferi, an agent of Lyme disease; (2) Anaplasma 
phagocytophilum, an agent of human anaplasmosis; (3) Babesia microti, an agent of 
human babesiosis; (4) Borrelia miyamotoi, an agent of relapsing fever; and (5) the 
Powassan encephalitis virus. Two or more of these pathogens can be transmitted either 
simultaneously by a single tick or sequentially by successive tick-bites, resulting in 240 
different permutations of mixed-infection studies. In the context of pathogen prevalence 
of Ixodes scapularis nymphs, Borrelia burgdorferi has been found in 19.8 percent of 
samples from the Northeast and Midwestern United States, while Babesia miroti has 
been found in 14.7 percent of samples from Block Island, Rhode Island. 
 Professor Fish explained that several types of co-infections have been explored 
in an experimental system employing laboratory colonies of I. scapularis ticks and 
Peromyscus leucopus white-footed mice, a natural reservoir host for these pathogens. 
Outcomes of mixed infections in mice have been measured by Ro, the fitness parameter 
and basic reproductive rate which indicates the number of secondary tick infections 
resulting from a primary infection (Levin and Fish, 2004). The observed outcomes of 
dual mixed infections have been variable with both positive and negative effects on Ro, 
while interactions have been mutual, unidirectional or null. These diverse pathogen 
interactions play an important role in determining the infection prevalence of host-
seeking nymphs in nature, and consequently, in the risk of infection for humans. 
   
Professor H. Henttonen (Finnish Forest Research Institute, Vantaa, Finland) and his 
team H. Leirs, E. R. Kallio, K. Tersago and L. Voutilainen in collaboration with 
University of Antwerp, Belgium; University of Liverpool, United Kingdom; and the 
Universities of Helsinki and Jyväskylä, Finland, studied Biome Specific Rodent 
Dynamics and Hanta Epidemiologies in Europe. Their research sought to understand 
the main biomes and forest coverage in Europe, the European hanta viruses and their 
carriers, and the biome specific dynamics of hanta virus carriers and the biome specific 
transmission dynamics and epidemiologies.    
Within the Bunyaviridae family of viruses, hantaviruses infect rodents (and 
insectivores) and cause haemorrhagic fever with renal syndrome (HFRS) in humans in 
the Old World and hantavirus cardiopulmonary syndrome (HCPS) in the New World. In 
a large European Union project, EDEN (Emerging Diseases in a Changing European 
Environment, 2011), rodent-borne (robo) viral infections have been studied, along with 
tick-borne pathogens, leishmaniasis, West Nile Virus, malaria and Rift Valley Fever. 
The most important aim of Professor Henttonen and his colleagues was to clarify the 
differences in boreal (Northern) and temperate Europe in the human epidemiology of 
nephropathia epidemica, by far the most common hantaviral disease in Europe, caused 
by Puumala hantavirus (PUUV). The population dynamics of the host species, the bank 
vole, differ greatly in various parts of Europe, driven by predation in the north and 
masting events in the temperate zone. Consequently, the causes of rodent fluctuations 
are different. In addition, the role of landscape patterns (homogenous Taiga vs. 
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fragmented temperate forests) in rodent/virus dispersal is significant, as well as local 
environmental conditions (e.g. temperature and moisture), which affect virus survival 
outside the host. For example, in room temperature PUUV remains infectious for at 
least two weeks outside the host, and possibly for much longer in cold temperatures and 
in moist conditions. These research findings are essential for human risk evaluation with 
regard to both long-term and seasonal occurrence of PUUV in the environment. In spite 
of chronic infection of bank voles and the excretion of PUUV in their faeces, urine and 
saliva, the shedding period is limited, which has significant implications for seasonal 
transmission dynamics in rodents. Thus within the same host/virus system, biome 
specific PUUV epidemiologies occur (Kallio et al., 2009. Tersago et al., 2009), thereby 
highlighting the need for geographically comparative studies in Europe (METLA, 
2012). 
 
Professor V. Sambri and his team, P. Gaibani, F. Cavrini, A. M. Pierro, M. P. Landini
 
and G. Rossini (all Regional Centre for Microbiological Emergencies [CRREM], Unit 
of Clinical Microbiology, St Orsola-Malpighi University Hospital, Bologna, Italy) 
investigated Usutu: A Novel Human Pathogenic Mosquito-borne Flavivirus. This 
virus belongs to the Japanese encephalitis serogroup within the mosquito-borne cluster 
of the genus Flavivirus in the family Flaviviridae. First isolated from mosquitoes of the 
genus Culex in South Africa in 1959, the Usutu virus (USUV) has since been isolated 
from mosquitoes, rodents and birds throughout Sub-Saharan Africa and Europe. The 
virus is thought to be maintained in nature in a mosquito-bird transmission cycle in 
areas with a minimum of at least ten hot days >30
o
C, but no mammalian reservoir has 
yet been identified.  
Professor Sambri pointed out that it was not until September 2009 that USUV 
was found in the liver of a patient who underwent an orthotropic liver transplant 
(Gaibani et al., 2010). Further study of the plasma and genome sequencing analysis 
confirmed the presence of USUV viremia. Then USUV was detected in the livers of an 
additional four patients from the same area suffering from acute meningo-encephalitis 
during 2008/2009. Both serological assay and molecular assay have been used as new 
tools for the diagnosis of USUV infection. Thus it is now clear that USUV is a new 
emerging flavivirus pathogenic for humans.  
Further studies are required to discover both the geographic distribution of this 
virus and the mechanisms by which humans acquire the virus. Since this conference 
presentation there has been increased awareness of the seriousness of USUV (Vázquez 
et al, 2011).  
 
According to the World Health Organization (WHO) and UNICEF (2009), 1.5 million 
children under the age of five die from diarrhea annually. Professor S. Schultz-Cherry 
and her colleagues, A. Burnham and P. Freiden (all Department of Infectious Diseases, 
St Jude Children’s Hospital, Memphis, TN, USA), L. A. Moser (Department of Medical 
Microbiology and Immunology, University of Wisconsin, Madison, WI, USA) and M. 
D. Koci
 
(Department of Poultry Science, North Carolina State University, Raleigh, NC, 
USA) presented the evidence they had gathered on the Identification of a Novel 
Astrovirus Enterotoxin: Potential Zoonotic Risk? 
Astroviruses cause infections within the small intestine and are associated with 
at least 10 percent of all sporadic cases and greater than 25 percent of all hospitalised 
cases. These rapidly evolving, nonenveloped, single-stranded RNA viruses can be 
transmitted directly from infected individuals and animals, and indirectly through 
contaminated food and water. Professor Schultz-Cherry’s laboratory was the first to 
demonstrate that astroviruses induce diarrhea by a novel mechanism: they possess an 
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enterotoxin that disrupts intestinal epithelial barrier function independent of cellular 
damage or an inflammatory response (Koci et al., 2003). This occurs within 24 hours 
post-infection due to reorganization of the tight junction protein occludin and the actin 
cytoskeleton (Moser et al, 2007).  
In essence, within a complex pathogenic process, astroviruses cause diarrhea by 
increasing intestinal barrier permeability. This is the first evidence showing that a viral 
coat protein is an enterotoxin. Of great interest, the toxin can act independently of 
species barriers. Given the increasing isolation of astroviruses from diverse species, 
there is increasing evidence that toxicogenic astroviruses could be associated with 
zoonotic disease.  
 
Professor M. G. Katze (Department of Microbiology and Washington National Primate 
Research Center, University of Washington, Seattle, WA, USA) set out a unifying 
approach to molecular biology in his presentation, Systems and Computational 
biology: Emerging Tools for Exploring Emerging Viruses. He emphasized that 
modern day virologists and immunologists must do better in their search to understand 
how a virus kills and how effective vaccines can be developed, especially because 
traditional virology has yielded surprisingly little information about why some virus 
strains cause severe diseases while others remain innocuous. He pointed out that the 
case fatality rate for the 1918 influenza pandemic was about 2.5%, and that particular 
H1N1 virus may have infected as much as one-third of the world’s population. Issues 
arise not only in understanding a virus, but also in understanding how hosts respond. 
For example, the 1918 virus infection resulted in very high expression of inflammatory, 
antiviral and immune cell genes very early in host infection (Kash et al., 2006). 
Significant progress in overcoming existing and emerging viruses depends on 
biologists, mathematicians and computer specialists working together within a systems 
biology paradigm. Such research begins with either in vitro studies of virus replication 
on cell lines or primary cell cultures, moving to nonhuman primate models of virus 
infection. Then samples from the experiments are investigated at multiple time points 
and conditions; and high throughput data is then examined by data processing to prepare 
systematic evaluations of different host responses. Data integration involving data 
analysis and modeling of key genes and pathways is then possible, followed by iterative 
processing of host perturbations and the use of viral mutants to discover specific 
applications to translational research. Such a systems biology approach requires not 
only continuing experiments with virus-infected experimental systems but also 
significant efforts to maintain the hardware and software of an extensive lab 
computational infrastructure. It is this computing infrastructure, which permits the lab to 
go quickly from samples to pathway visualization, as the data analysis workflow moves 
from microarray images to gene expression data to pathway models. 
The mission of this ViroLab is to develop steadily over the years to come a 
virtual laboratory to confront the viruses involved in 14 infectious diseases—influenza, 
Ebola, Marburg, Hepatitis C, SARS-CoV, vaccinia, Herpes simplex, West Nile, HIV-1, 
SIV, measles, Lassa, Chikungunya and Dengue Fever. The three key characteristics of 
this integrated approach to so many infectious diseases are: (1) to use cell culture, 
primary cells, nonhuman primate and human clinical models to study viral infection; (2) 
to combine traditional histopathological, virological and biochemical approaches with 
functional genomics, proteomics and computational biology  (Haagmans et al., 2009); 
and (3) to obtain signatures of virulence and insights into mechanisms of host defense 
response, viral evasion and pathogenesis (Casadevaill et al., 2011). For example, with 
the study of all respiratory viral diseases a unifying hypothesis is that highly pathogenic 
respiratory viruses use both unique and common strategies to remodel the host cell to 
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enhance virus replication, regulate disease severity and promote virus transmission 
(Chang et al, 2011). 
A highly significant new tool for studying these emerging viruses is Next 
Generation Sequencing (NGS) which has already ‘changed the way we think about 
scientific approaches in basic, applied and clinical research’ to such an extent that ‘the 
potential of NGS is akin to the early days of Polymerase chain reaction (PCR), with 
one’s imagination being the primary limitation to its use’ (Peng et al, 2011). Already, a 
good understanding of the ‘timing’ and extent of immune (innate) mediated injury after 
virus infection has been achieved. Furthermore, molecular ‘disease’ signatures 
associated with different pathogens in multiple animal species have been described at 
microRNA, mRNA, protein level, metabolite and lipid levels. Such successful 
modelling of molecular events has made possible verifiable prediction about key nodes 
and bottlenecks, enabling the identification of novel host cell drug targets (Diamond et 
al, 2010). The translational impact of this research, in Professor Katze’s view, will be 
immense, revealing a completely new and expanded host defense repertoire consisting 
of non-annotated non-coding RNAs. 
 Despite all of these achievements, four crucial questions remain unanswered:  
(1) Is systems biology too complicated and too expensive to become the pre-eminent 
approach in virology and immunology? (2) Are mathematicians and computer scientists 
up to the challenges? (3) How will new technologies like Next Generation Sequencing 
impact virus systems biology research, especially in the context of RNA sequencing? 
and (4) How can new principal investigators best be identified and appointed? 
(ViroLab, 2012).  
   
2. The Role of Wildlife in Emerging Zoonoses  
It has long been recognized that the emergence of any zoonoses is a complex process 
involving ‘ecological interactions at the individual, species, community and global 
scale’ (Childs et al. 2007, p.2). This topic began with a presentation from Professor A. 
A. Aguirre that focused on the ecological framework in which any zoonotic disease 
should be considered. The role of bats as an important reservoir host for many 
dangerous zoonotic pathogens was then considered in some detail (cf. Daniels et al., 
2007; Field et al., 2007; Gonzalez et al., 2007; Wang and Eaton, 2007).    
 
Professor A. A. Aguirre (Department of Environmental Science and Policy, George 
Mason University and Executive Director, Smithsonian-Mason Global Conservation 
Studies Program, Front Royal, Virginia, USA) presented Emerging Zoonotic Diseases 
of Wildlife: Developing Global Capacity for Prediction and Prevention. He began 
by explaining that Conservation Medicine and more recently EcoHealth have 
emphasized the need to bridge disciplines, thereby linking human health, animal health, 
and ecosystem health under the paradigm that ‘health connects all species in the planet’ 
(Aguirre et al., 2002).  In his view, the recent convergence of global problems such as 
climate change, biodiversity loss, habitat fragmentation, globalization, infectious 
disease emergence and ecological health demands integrative approaches breaching 
disciplinary boundaries. The International Union for Conservation of Nature (IUCN) 
maintains a Red List of threatened species—an important initiative in view of the 869 
animal extinctions that have already occurred, of which 3.7 percent were caused by 
disease (Smith, K. F. et al., 2006).    
Professor Aguirre noted that the U.S. Agency for International Development 
(USAID) has been a major leader in the global response to the emergence and spread of 
Highly Pathogenic Avian Influenza (HPAI). Since mid-2005, it has programmed 
approximately $500 million to build capacities in more than 50 countries for monitoring 
 7 
the spread of HPAI among wild bird populations, domestic poultry, and humans, and to 
mount a rapid and effective containment of the virus when it is found.  Recent analyses 
indicate that these efforts have contributed to significant downturns in reported poultry 
outbreaks and human infections and a dramatic reduction in the number of countries 
affected. Furthermore, the USAID Bureau for Global Health, Office of Health, 
Infectious Disease and Nutrition (GH/HIDN) recently funded two cooperative 
agreements, PREDICT and RESPOND, under its Avian and Pandemic Influenza and 
Zoonotic Disease Program to continue and expand this work. The goal of PREDICT is 
to establish a global early warning system for zoonotic disease emergence that is 
capable of detecting, tracking, and predicting the emergence of new infectious diseases 
in high-risk wildlife (e.g. bats, rodents, and non-human primates) that could pose a 
major threat to human health. The goal of RESPOND is to improve the capacity of 
countries in high-risk areas to respond to outbreaks of emergent zoonotic diseases that 
pose a serious threat to human health.  The geographic scope of this expanded effort is 
directed to zoonotic ‘hotspots’ of wildlife and domestic animal origins (Jones et al., 
2008).         
PREDICT includes a program of SMART (Strategic, Measurable, Adaptive, 
Responsive and Targeted) surveillance which focuses on preventing the “spilling over” 
from wildlife to humans or to halt these diseases rapidly after that spillover by 
understanding what factors induce emergence and rapidly identifying ways of 
prevention, control, and mitigation. The overall aim of SMART is to promote an 
integrated, global approach to emerging zoonoses. This integration requires 
commitment from a broad coalition of partners and stakeholders including government 
agencies, universities and non-governmental organizations, collaborating for specific 
purposes and to generate in the future new international structures able to respond to 
these emerging zoonoses. With 1.5 billion animals being imported into the United 
States each year, as well as an extensive international trade in illegal animal exports 
(Smith K. F. et al., 2009) and some 75 percent of emerging zoonoses worldwide having 
wildlife origins, Professor Aguirre stressed that EcoHealth has become a necessity, not 
an optional policy goal.   
Dr. G. A. Marsh and his colleague Dr. L.-F. Wang (Australian Animal Health 
Laboratory [AAHL], Geelong, Victoria, Australia) began their presentation, Bats: A 
Mixed Bag of New and Emerging Viruses, by pointing out that the “old” bat viruses 
were represented by many zoonotic pathogens, including Rabies virus, Yellow fever 
virus, St Louis and Japanese encephalitis viruses, and West Nile virus. Now bats have 
been identified as natural reservoirs for a number of new and emerging viruses—Ebola 
virus, Marburg virus, Hendra virus and SARS-like coronaviruses. There are some 1,000 
different bat species; and they often roost in high density colonies of over one million 
flying mammals, which have, in a very real sense, been travelling for millions of years, 
exposing themselves to many pathogens; therefore, the resulting complexity is not 
surprising.  Key research questions include: (1) Why do bats seem to be able to co-exist 
with a great diversity of viruses without showing disease signs? (2) What triggers the 
spillover of bat viruses into other animals? (3) Do bats control viral infection differently 
from other mammals? 
Attempts to isolate viruses from bats have generally been unsuccessful. Therefore, 
in an effort to improve the success rate for virus isolation, Dr. Marsh and his team have 
recently developed primary cell culture lines from numerous different species of bats 
(Crameri et al., 2009). The use of these bat cell lines, in combination with improved 
sampling techniques, has lead to recent isolation of Hendra virus from a number of bat 
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urine samples collected in several locations across Queensland, Australia, including 
those associated with human and horse virus spill-over events (Smith, I. et al, 2011). 
Furthermore, this henipavirus surveillance program has led to the isolation of a number 
of novel viruses from two different virus families, whose zoonotic potential is not yet 
known. In an attempt to understand virus/host interactions, as well as to provide insight 
into the key factors involved in future spill-over events, AAHL has launched a number 
of international collaborative projects in Southeast Asia and Ghana, West Africa.  
C. Kohl and her colleagues M. Sonntag, A. Nitsche and A. Kurth (Robert Koch 
Institute, Berlin, Germany), B. Harrach (Veterinary Medical Research Institute, 
Hungarian Academy of Sciences, Budapest, Hungary), K. Mühldorfer and G. Wibbelt 
(Leibniz Institute for Zoo and Wildlife Research, Berlin, Germany) presented 
Adenovirus with Bat Origin: Possible Intra-Species Transmission. They reported 
that since bats have been reported as reservoir hosts of emerging pathogens, research 
interest in their inhabiting viruses has significantly increased. A novel bat Adenovirus 
(bat AdV-2) was isolated by cell-culture screening from organ tissue of free-ranging  
vespertilionid bats (Pipistrellus pipistrellus) in Germany (Sonntag et al., 2009). The 
phylogenetic analysis of the genome sequence of bat AdV-2 demonstrated a close 
relationship to canine adenovirus 1 and 2 (CAdV-1 and -2) (Kohl et al., 2012). The very 
similar genome organization supported the hypothesis of a shared ancient ancestor. 
Interestingly, both CAdVs are presenting untypical pathological features within the 
family Adenoviridae. These adenoviruses were found to have an unusually broad host 
range and are causing a rather higher pathogenicity in a variety of carnivore hosts. The 
untypical pathological features might be understood as signs of a missing adaptation 
host and could provide a model to study ancient inter-species transmission events. 
  
3. Cross-Species Transmission of Zoonotic Pathogens 
This section of the conference addressed cross species transmission of selected 
pathogens.  In addition to the summaries below of three presentations on this topic, this 
Special Supplement includes an article, Epidemiological Survey of Tryanosoma cruzi 
Infection in Domestic Owned Cats from the Tropical Southeast of Mexico by Dr. 
M. Jiménz-Coello et al. setting out how a significant public health problem in Mexico 
has been caused by the cross-species transmission of American Trypanosomiasis (AT) 
from triatomine bugs to domestic cats, representing a potential risk to humans. 
 
Speaking on behalf of an extensive team of collaborators from a number of 
institutions—C. Osborne, P. Cryan, T. J. O’Shea, L. M. Oko, C. Ndaluka, C. H. 
Calisher, A. Berglund, M. L. Klavetter, R. A. Bowen and K. V. Homes—Dr. S. R. 
Dominguez (Section on Pediatric Diseases, The Children’s Hospital, University of 
Colorado School of Medicine, Aurora, CO, USA) began by noting that the first 
pandemic of the 21st century, the deadly SARS virus, had its natural reservoir in bats.  
In his presentation, Alphacoronaviruses in New World Bats: Prevalence, 
Persistence, Phylogeny and Potential for Interaction with Humans, he suggested 
that bat coronaviruses (CoVs) may well be the ancestors of all group 1 and 2 CoVs. 
Today bats had become a primary species encountered by humans in terms of potential 
exposure to significant disease agents. Their research was tackling three important 
unanswered questions: (1) What is the prevalence and diversity of bat CoVs in New 
World bats? (2) Do bat CoVs persist in bat populations and/or individual bats? and (3) 
What are the potential interactions of infected bats with the human population? 
A three-year study (Osborne et al., 2011) had collected clinical and 
environmental samples from bats at 16 rural sites and 5 urban sites throughout 
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Colorado, as well as bat carcasses obtained from various counties throughout the state 
from the Colorado Department of Public Health and Environment. Of the 1,002 fecal or 
anal swab samples, 75, that is 7 percent, were positive for CoV RNA. The highest 
prevalence of the virus was in juvenile bats; and although rates of prevalence varied 
from year to year, late spring was the time when the virus peaked. Although bat CoVs 
persisted within bat populations and their roosts, individually tagged CoV-infected bats 
cleared their infections within 6 weeks without apparent illness. New world bats of the 
same species in geographically distinct locations and over the course of several years 
harbour similar CoVs; and some New World bat CoVs may be able to infect bats of 
different genera. Strikingly, bats, which had known or potential contact with humans 
had a high prevalence of 10 to 20 percent of CoV infection. It is clear that significant 
opportunities exist for zoonotic transmission of coronaviruses from bats to humans and 
vice versa, especially as more than 95 viruses have already been isolated from or 
detected in bat tissues. 
 
Noting that many mammalian and avian species in addition to bats are susceptible to 
coronavirus infection, Professor K. V. Holmes and her colleagues, K. Guo, Z. Qian and 
S. Wennier (Department of Microbiology, University of Colorado School of Medicine, 
Aurora, CO, USA) and G. Peng and F. Li (Department of Pharmacology, University of 
Minnesota Medical School, Minneapolis, MN, USA) presented the Emergence and 
Evolution of Alphacoronaviruses: Insights from Spike and Receptor Analysis. 
Some coronaviruses can only infect a single host species, while others can infect 
multiple species, because coronavirus host range is determined, in part, by specific 
interactions of the viral spike protein, S, with cellular receptor proteins that include 
ACE2, APN and CEACAM1. The recent emergence of SARS coronaviruses from 
civets, bats and/or other reservoir species into humans depended upon a few amino acid 
substitutions in the receptor-binding domain (RBD) of S from the animal viruses that 
allowed them to recognize human ACE2 instead of, or in addition to, receptors of their 
natural hosts (Li, 2008). 
Alphacoronaviruses of pigs, cats, dogs and human coronovirus 229E use APN 
receptors of the host species, and all four viruses recognize feline APN (Tusell et al., 
2007). In contrast, for human alphacoronavirus NL63, the receptor-binding motif 
(RBM) with its three loops in the RBD binds specifically to human ACE2. In the RBDs 
of the cat virus, FIPV, Professor Holmes and her research team predicted 3 loops 
structurally similar to the NL63 RBMs; and they constructed chimeric FIPV RBDs 
containing one, two or three RBMs from NL63. Receptor binding assays using enzyme-
linked immunoassays (ELISA), flow cytometry and co-immunoprecipitation identified 
3 loops (RBMs) in FIPV RBD that are required for binding to feline APN. Furthermore, 
substitution of only a few key amino acid residues within the RBMs of FIPV altered 
APN specificity and viral host range. Thus the emergence of alphacoronaviruses into 
new host species can occur when spontaneous mutations arise in the RBMs that permit 
binding to variants of the APN receptor protein expressed by different host species. 
  
  
Considering the interaction between human and swine H1N1 viruses since 1900, 
Professor H. D. Klenk (Institute of Virology, Philipps University, Marburg, Germany) 
presented the Mechanisms of Pathogenicity and Host Adaptation of Influenza 
Viruses in the Light of the New H1N1 Pandemic. He explained that there was now a 
clear scientific consensus that wild aquatic birds are the natural hosts for a large variety 
of influenza A viruses. Occasionally these viruses are transmitted from this reservoir to 
other species, such as chickens, pigs and humans, leading to devastating outbreaks in 
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domestic poultry and the possibility of human influenza pandemics. By the end of 
February 2010, there had been 15,921 deaths, with the World Health Organization later 
confirming cases in 171 countries and territories, with deaths in at least 139 countries 
and territories before the spread of the H1N1 virus diminished. However, Professor 
Klenk set out the evidence to support his view that the pathogenic and pandemic 
potential of this new H1N1 virus is not yet exhausted. 
The host range and pathogenicity of any virus are polygenic traits depend on the 
interaction of different viral proteins with specific host factors. It has long been known 
that proteolytic activation and receptor specificity of the hemagglutinin (HA) are 
important determinants for pathogenicity and interspecies transmission, respectively. 
There is now considerable evidence that HA mutations altering receptor specificity and 
cell tropism of the 2009 pandemic influenza A virus (H1N1v) are linked to the D222G 
amino acid substitution and are associated with a particularly severe outcome of 
infection (Liu et al., 2010).. It should be remembered that the viral polymerase has to 
enter the nucleus of the infected cell in order to promote replication and transcription of 
the viral genome. Adaptive mutations in polymerase subunits of avian viruses improve 
binding to importin Alpha, a component of the nuclear pore complex in mammalian 
cells. As a result, nuclear transport of these proteins and efficiency of replication are 
enhanced. Thus, the interaction of the viral polymerase with the nuclear import 
machinery is an important determinant of host range.  
Some of the structural features typical for avian viruses have been preserved in 
the polymerase of the 2009 pandemic influenza A virus (H1N1v) suggesting that this 
virus has the potential to further adapt to humans. Recent studies have shown that the 
NS1 protein, another important determinant of pathogenicity and host range, is 
SUMOylated, and that this modification enhances virus growth. Interestingly, NS1 of 
H1N1v is not SUMOylated (Xu et al., 2011). Taken together, these observations 
support the view that the pathogenic and pandemic potential of the new virus is not yet 
exhausted. Furthermore, because of the firm evidence of HA polymorphism in position 
222, mutants and other mutations with altered receptor specificity will have to be 
closely monitored.  
In the subsequent discussion it was noted that when a virus becomes highly 
pathogenic, this might block its spread if additional hosts are not readily available. 
Furthermore, the role of co-infection with bacterial inflection was highly relevant in the 
1918-1919 influenza pandemic and might well be relevant in a future pandemic. 
  
4. Emerging and Neglected Influenza Viruses 
There have been at least three influenza pandemics every century since 1700, with some 
evidence of earlier epidemics and pandemics after 1500. In The Cambridge World 
History of Human Disease, A. W. Crosby (1993; p. 810) has noted that although the 
black death and World Wars I and II killed higher percentages of the populations at risk, 
the 1918-1919 influenza pandemic was possibly ‘in terms of absolute numbers, the 
greatest single demographic shock that the human species has ever received’. The 
summaries below of seven presentations on this topic highlight the diversity of 
influenza viruses in North America (cf. Nelson et al., 2011), while other relevant 
research has been published with respect to Swine Influenza Viruses (SIVs) in Europe 
(Kyriakis et al., 2009)   
Considerable research has now been done  into how the Highly Pathogenic 
H5N1 Avian Influenza virus spreads from wild birds and ducks to chickens and other 
species, including humans (Rabinowitz et al., 2009; Ma et al, 2008). The studies of how 
influenza viruses can be genetically altered to become more transmissible have become 
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a matter of much controversy (Palese and Wang, 2012; L. H. Kahn, 2012). In addition 
to the summaries below, this Special Supplement includes an article, Lessons from 
Emergence of A/goose/ Guangdong/1996-like H5N1 Highly Pathogenic Avian 
Influenza Viruses and Recent influenza Surveillance Efforts in Southern China, in 
which Dr. X.-F. Wan has considered the emergence and ecology of Influenza A Viruses 
in Southern China, especially the highly pathogenic H5N1 virus.   
Backed by an extensive team of collaborators, Professor A. D. M. E. Osterhaus (Head, 
Department of Virology, Erasmus Medical Centre, Rotterdam, The Netherlands) began 
his presentation, Emerging and Neglected Influenza Viruses, by explaining the 
complex aetiology of the Influenza A, B and C viruses. While humans can serve as host 
species for all three viruses, Influenza A can also be present in other mammals and 
avian species, Influenza B in seals, and Influenza C in pigs. The severity of the disease 
is relatively high with Influenza A, moderate with Influenza B and low with Influenza 
C, with the prevalence in humans high with both Influenza A and B viruses, but lower 
with Influenza C. Furthermore, a clear distinction needs to be made between seasonal 
influenza, avian influenza and pandemic influenza. There are two different mechanisms 
of host adaptation—sequential mutations and genome reassortment.  Most recently, the 
new H1N1 swine flu pandemic outbreak of 2009 drew attention to the speed with which 
an influenza virus could move around the world. However, the fact that this particular 
virus was not as virulent as first anticipated proved crucial in confronting the virus, even 
though it spreads rapidly among humans, unlike the much more virulent H5N1 avian flu 
virus, from which more than 300 people have died from more than 500 verified cases 
from 2003 to 2011 (WHO, 2012).  
 Although clinical evidence of H5N1 avian influenza appears predominantly in 
diving ducks, a number of dabbling duck species—Mallard, Teal, Wigeon and 
Gadwall—appear to spread H5N1, generally acquired from wild birds, without showing 
major signs of disease. The likelihood of a major pandemic linked to H5N1 has not 
decreased in the last five years, even though publicity has certainly decreased. 
Furthermore, Professor Osterhaus pointed out that the recent H1N1 pandemic influenza 
outbreak indicated that the scientific community was wrong in its earlier belief that ‘a 
pandemic strain could only arise from a subtype that had not previously been widely 
disseminated in humans [because] the H1N1 virus has shown that human varieties 
characterized by different hemagglutinin (HA) molecules may follow separate lines of 
evolution and may generate potentially pandemic strains within an existing human HA 
subtype. Hence, it is essential to develop methods for estimating how many 
antigenically different subtypes may reside within each HA type’ (cf. Rappuoli et al., 
2009).  
In the light of the continuing prevalence of many subtypes of influenza, there is 
a critical need for improved monitoring, especially in Asia and Africa, as part of a move 
from a reactive to a proactive approach, with greater research into the possibility of 
developing a universal vaccine. Although there are increasing opportunities for virus 
infections to emerge and spread rapidly in our global society, new tools are being 
provided by research in molecular biology, epidemiology, genomics and bioinformatics. 
Already early warning systems based on state of the art virus detection techniques, as 
well as targeted intervention strategies based on data about the mutual virus-host 
interaction have been instrumental in dealing with numerous viral threats, including 
SARS and avian influenza. 
 
The extensive research of the Department of Virology at Erasmus Medical Centre in 
Rotterdam was highlighted by a further presentation, Influenza Pneumonia: The Role 
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of the Alveolar Macrophage, given by Dr. D. van Riel. Highly pathogenic avian 
influenza (HPAI) H5N1 virus causes severe, often fatal, pneumonia in humans. The 
pathogenesis of HPAI H5N1 virus is not completely understood, although the alveolar 
macrophage (AM) is thought to play an important role. The AM resides in the 
pulmonary alveolus, the primary site of HPAI H5N1 virus replication in humans. It had 
been  shown previously that HPAI H5N1 virus attaches abundantly to these AM (van 
Riel et al., 2006). The aim of this study was to determine the response of primary 
human AM to HPAI H5N1 virus, seasonal H3N2 virus or pandemic H1N1 virus, and to 
compare these responses with that of macrophages cultured from monocytes.  
HPAIV H5N1 infection of AM compared to that of macrophages cultured from 
monocytes resulted in a lower percentage of infected cells (up to 25% versus up to 
84%), lower virus production and lower TNF-alpha induction. Infection of AM with 
H3N2 or H1N1 virus resulted in even lower percentages of infected cells (up to 7%) 
than with HPAI H5N1 virus, while virus production and TNF-alpha induction were 
comparable. In conclusion, this study revealed that macrophages cultured from 
monocytes are not a good model to study the interaction between AM and influenza 
viruses. Furthermore, the interaction between HPAI H5N1 virus and AM could 
contribute to the pathogenicity of this virus in humans, due to the relatively high 
percentage of infected cells rather than virus production or an excessive TNF-alpha 
induction (van Riel et al., 2011).   
 
Dr. E. A. Govorkova presented the study, Fitness of Highly Pathogenic H5N1 
Influenza Viruses in Ferrets, on behalf of a research team at St. Jude Children’s 
Research Hospital Center of Excellence for Influenza Research and Surveillance (St. 
Jude CEIRS), Memphis, TN, USA which included N. A. Ilyushina, B. M. Marathe and 
R. G. Webster. She began by pointing out that while the neuraminidase (NA) inhibitors 
are currently our first line of defense against a pandemic threat, the potential emergence 
of virulent and transmissible drug-resistant H5N1 viruses has important clinical 
implications (Writing Committee, 2008; White et al, 2009). 
      The St Jude’s CEIRS research team used reverse genetics techniques and generated 
two pairs of H5N1 recombinant viruses: A/Vietnam/1203/2004-like (HA clade 1) and 
A/Turkey/15/2006-like (HA clade 2.2). One virus of each pair was wild-type, while the 
other carried the H274Y NA mutation conferring resistance to NA inhibitor oseltamivir. 
Within each pair, the wild-type and oseltamivir-resistant virus caused disease of equal 
severity in ferrets and replicated to comparable virus titers in the upper respiratory tract. 
Then, in order to assess the fitness of drug-resistant H5N1 influenza viruses, the 
research team considered virus-virus interactions within the host by co-inoculating 
ferrets with mixtures of the oseltamivir-sensitive and oseltamivir–resistant H5N1 
viruses in varying ratios (e. g. 100/0; 80/20; 50/50; 20/80; 0/100). Using this novel 
approach, they demonstrated that the proportion of A/Vietnam/1203/2004-H274Y 
clones tended to increase while the proportion of A/Turkey/15/2006-H274Y clones 
tended to decrease. Their findings suggest that the H274Y NA mutation can affect the 
fitness of two H5N1 viruses differently and is dependent on background NA sequence. 
Dr. Govorkova pointed out that antigenic and genetic diversity, virulence, the degree of 
NA functional loss of H5N1 virus and differences in host immune response can also 
contribute to such differences. Therefore, the risk of emergence of drug-resistant 
influenza viruses with uncompromised fitness should be monitored closely and 
considered carefully in pandemic planning. 
In a collaboration with C. Corzo, K. Juleen and M. Gramer (University of Minnesota 
Veterinary Diagnostic Laboratory, St Paul, MN, USA) and J. Lowe (Carthage 
Veterinary Services, Carthage, IL, USA), Dr. R. Webby and his colleagues at St Jude 
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Children’s Research Hospital in Memphis, M. Ducatez, E. Stigger-Rosser, D. Wang and 
D. Darnell sought to answer the question: Is disease surveillance collected from 
diseased animals giving a true picture of swine flu activity in the United States?  
       They initiated an active surveillance program in healthy pigs in multiple sites in 
2009, during a period coincident with the emergence of the H1N1 pandemic in humans. 
Their study, Active Surveillance for Influenza Viruses in North America, presented 
an analysis from 12 months of data which indicated that similar viruses can be detected 
in both active and passive surveillance schemes, and that there has been an explosion of 
diversity in swine influenza viruses (SIV) in the United States. Not only were a number 
of pandemic H1N1 infections in swine detected, but a number of pandemic/endemic 
swine virus reassortants were found, albeit from healthy animals (Ducatez et al., 2009). 
Virologically, the pattern of disease surveillance grounded in the activities of state 
diagnostic laboratories collecting information from diseased animals is representative; 
however, epidemiologically this data from diseased animals is not representative. 
Reverse zoonoses have had a huge impact on SIV in the United States (Vincent et al, 
2008) and the pandemic virus is now endemic. However, in considering whether any 
particular reassortment causes alarm, it must be acknowledged that there is not yet a 
good model of risk, so H3, like H1, is going to be found in pigs for some time to come, 
but the consequences of this diversity in SIV are not yet clear.  
  
The extensive collaboration now taking place in the study of swine influenza was 
evident in the presentation by Dr. K. M. Lager (Virus and Prion Diseases of Livestock 
Research Unit, National Animal Disease Center, US Dept of Agriculture, Agricultural 
Research Service [USDA-ARS], Ames, IA, USA) on behalf of his colleagues P. C. 
Gauger, L. C. Miller and M. E. Kehrli, Jr., as well as other members of the research 
team, several with multiple institutional affiliations including D. A. Senne and D. L. 
Suarez (National Veterinary Services Laboratories, USDA, Veterinary Services, Ames, 
IA), D. E. Swayne (Southeast Poultry Research Laboratory, USDA-ARS, Athens, GA), 
and J. A. Richt and W. Ma (Kansas State University, Manhattan, KS, USA). Their 
consideration of The Mixing Vessel Pendulum began by explaining the three elements 
of how swine could be considered as a mixing vessel for influenza A viruses as formally 
proposed by Scholtissek et al (1985): (1) Swine are susceptible to infection with 
influenza A viruses from avian and human viruses; (2) The avian viruses can adapt 
within the pig, producing novel reassortants; and (3) These reassortants can then be 
shed and are infectious to man. The goal of this presentation was to test the first part of 
the mixing vessel hypothesis, concerned with the susceptibility of swine to avian and 
human influenza viruses, making use of both mixing vessel studies in pigs and genetic 
markers to investigate adaptation. 
     Dr. Lager noted that the emergence of the H5N1 highly pathogenic avian influenza 
virus that can transmit from avian species directly to man, and the presumption that the 
1918 H1N1 influenza jumped from birds to man has expanded our understanding of the 
swine mixing vessel hypothesis as a potential, but not exclusive, source of human 
pandemic viruses (Taubenberger et al, 2005). Moreover, the emergence of the 2009 
pandemic H1N1 virus has re-emphasised swine as a potential source of pandemic virus. 
In this study, all of the challenge viruses (avian H5, H7, H9) induced a similar effect in 
pigs; challenge viruses did replicate in pigs; the infections were subclinical with mild 
pneumonias; most infections resulted in seroconversion; and none of them transmitted 
to contact controls. This series of studies suggests pigs could be easily infected with 
avian viruses; however, an adaptation step is needed to generate fit viruses that transmit 
among swine. Parallel studies are currently underway testing the susceptibility of pigs to 
human seasonal influenza viruses. Future studies using reverse genetics could 
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investigate potential genetic markers for adaptation of avian viruses to swine which may 
provide insight into the interspecies transmission of influenza viruses. 
 
A further study of swine influenza viruses, In vitro and in vivo Characterization of 
Viral Reassortment between North American Triple Reassortant and Eurasian 
H1N1 Swine Influenza Viruses, was presented by Dr. W. Ma (Dept of Diagnostic 
Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, 
Manhattan, KS, USA) on behalf of his colleagues Q. Liu, J. A. Richt and C. Qiao, as 
well as G. del Real (Department of Biotechnology, Instituto Nacional de 
Investigaciones Agrarias [INIA], Madrid, Spain), A. Garcia-Sastre (Department of 
Microbiology, Mount Sinai School of Medicine, New York City, USA) and R. J. 
Webby (St. Jude Children’s Research Hospital, Memphis, TN, USA). The 2009 
pandemic H1N1 virus (pH1N1) was derived through the reassortment of a North 
American triple reassortant swine influenza virus (SIV) and an avian-like Eurasian SIV. 
However, to date, the exact mechanisms by which the pH1N1 arose are not understood.  
        In this study an attempt was made to recreate the 2009 pandemic virus by co-
infecting cells (in vitro) or a group of pigs (in vivo) with Eurasian (SP04) and North 
American triple reassortant (KS07) SIVs (Ma et al., 2010a). Infected pigs were co-
housed with two groups of sentinel animals to investigate virus maintenance and 
transmission. The origin of each gene segment of viruses was determined which were 
isolated from supernatants collected from co-infected cells or nasal swabs and 
bronchioalveolar fluid samples collected from infected and sentinel animals. Different 
reassortant viruses were identified from co-infected cell lines; however no virus with the 
genotype of pH1N1 was found. Less reassortant viruses were found in the lungs of co-
infected pigs in contrast to those in co-infected cells. Interestingly, only the intact KS07 
was detected from nasal swabs from the second group of sentinel pigs. These results 
demonstrated multiple reassortant events can occur within the lower respiratory tract of 
the pig; however, only a specific gene constellation is able to be shed from the upper 
respiratory tract. However,, in this study it was not possible to generate the pH1N1 
constellation using co-infection with the techniques described above and previously 
(Ma et al., 2010b).   
 
In a collaboration among four institutions, Dr. S. E. Belisle (Department of 
Microbiology and Washington National Primate Research Center, University of 
Washington, Seattle, WA, USA) presented a Systems Biology Approach to 
Understanding Influenza across Species on behalf of her colleague, M. G. Katze (of 
the same Center), W. Ma and J. A. Richt (Dept of Diagnostic Medicine/Pathobiology, 
College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA), T. M. 
Tumpey (Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 
USA) and H. Feldmann (Rocky Mountain Laboratories, Hamilton, MT, USA). She 
began by reflecting on the ability of swine to act as a reservoir for many influenza 
viruses, becoming infected with low mortality, regardless of influenza virus strain. The 
objective of the study was to further understand the porcine response to influenza and to 
compare this response to other animals infected with the same virus.  
To accomplish this objective, they used statistical and functional analysis of 
global gene expression to compare host transcriptional response during acute infection 
by a contemporary H1N1 pandemic influenza virus (A/California/04/2009) in swine, 
non-human primates and mice. Using their data, they compared and contrasted the 
biological pathways most significantly associated with gene expression changes during 
acute infection across these species. Their goal was to leverage data collected in their 
previous studies (Ma et al., 2011; Safronetz et al., 2011) to better understand influenza 
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virus pathogenesis through a cross-species analysis that considered three crucial 
questions: (1) Which genes change over the course of acute infection? (2) What are the 
top functions altered during infection? (3) How does functional response compare 
across the three species?  
 Despite challenges to data integration and interpretation, including the 
differences in transcript representation and annotation on the microarrays for the 
different species, the researchers found notable differences in response to influenza in 
the lungs of the three species. Although similar functional groups of genes changed with 
infection in all three species, the nature of that response was species-specific. Swine 
exhibited an elevated transcriptional response that tapered by resolution of influenza. 
Mice exhibited a decrease in many acute phase and immune response genes quickly 
followed by a steady increase in expression. Host response in macaques was most 
pronounced and maintained over time. In considering the transcription of immune-
related genes in swine, mice and nonhuman primates, they found that although the 
number of immune-related genes changing in each species was similar, the precise 
genes changing were very different, with only 14 immune response genes commonly 
differentially expressed across all three species. This suggested that the nature of 
immune response within each species may be quite different. 
 In response to the perennial question after any scientific experiment, “Where do 
we go from here?” they offered four ideas: (1) Time series analysis could reveal unique 
response kinetics across species, thereby leading to targeted analysis; (2) Data 
integration across multiple data types, including transciptomics, proteomics, miRNA 
and NGS could generate a more complex, multidimensional view of response; (3) As 
annotation of the different species-specific genomes improves, this information could be 
integrated into future analyses, making a better understanding of the biological 
responses to infection possible; and (4) The gathering of this additional information 
could empower more precise analysis on what makes each species uniquely susceptible 
or resistant to influenza. In the firm view of these particular six researchers, studies such 
as this are necessary for a deeper understanding of influenza pathogenesis and 
demonstrate the utility of systems biology in the study of emerging viruses.  
  
5. Hemorrhagic Fever Viruses 
 Three relevant articles on this topic have been published below, highlighting the global 
dimensions of both infection and treatment, no matter where the virus first emerges. The 
need for geographical comparative studies of the emerging hantavirus, Puumala 
hantavirus (PUUV), has already been indicated by Professor Henttonen and his team in 
their presentation summarized above in the opening topic of this Meeting Review. In a 
further investigation into the same hantavirus, Dr. Eckerle and her colleagues have 
presented an article within this Special Supplement entitled Atypical Severe Puumala 
Hantavirus Infection and Virus Sequence Analysis of the Patient and Regional 
Reservoir Host. In this article they focus on the difficulties in the diagnosis and 
treatment of a single patient and performed virus sequence analysis showing regional 
clustering in reservoir and host. In their more wide-ranging conference presentation they 
investigated cytokine expression in a cohort of patients hospitalized with acute severe 
hantavirus infection during an epidemic in Germany in 2010 (cf. Faber et al, 2010). 
Elevated pro-inflammatory cytokines during the early phase of disease compared to 
healthy controls and increase of immunsuppressive TGF-β from early to later phase of 
disease supported the hypothesis of an immune-mediated pathogenesis of Puumala 
hantavirus (Sadeghi et al, 2011). This finding indicates that the immune status of the 
host for old-world hantaviruses plays an important role, not only the virus itself. 
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In a further article published in this Special Supplement, How Ebola Virus 
Counters the Interferon System, A. Kühl and S. Pöhlmann have reviewed which 
components of the innate immune system could be effective against the zoonotic 
transmission of Ebola virus (EBOV) to humans, which results in severe hemorrhagic 
fever and high case-fatality rates. Their focus is on how the interferon (IFN) system, as 
a key innate defense against viral infections, is targeted by distinct EBOV proteins, and 
on how specific effector molecules of the IFN system could form a potent barrier 
against the spread of EBOV in humans.  
Finally, in Lassa Fever in West Africa: Evidence for an Expanded Region of 
Endemicity, Dr. N. Sogoba and his colleagues H. Feldmann and D. Safronetz, have 
stressed the importance of increased surveillance for Lassa virus across West Africa. 
The seven presentations summarized below cover a number of hemorrhagic 
fever viruses. For example, an important example of a highly contagious and life 
threatening hemorrhagic fever virus is Crimean-Congo hemorrhagic fever virus 
(CCHFV), caused by a tick-borne virus of the Bunyaviridae family (Elliott. 1990) First 
recognized in the Crimea in 1944, with an identical virus isolated in the Congo in 1956, 
the incidence and geographical spread of this disease with its high human fatality rate 
have increased significantly in the past ten years. However, the causes of this increase 
are not yet clear (Maltezou and Papa, 2011). In the light of the need to develop new 
therapies and effective, safe vaccines, the next seven research presentations could prove 
to be of considerable significance, not only for CCHFV, but also for the Hendra, Nipah, 
Lujo and Ebola viruses. Although these viruses have certain common features in their 
causes and consequences, each hemorrhagic fever virus needs to be carefully studied as 
a distinct entity.    
 
Dr. R. Rodrigues and her colleagues G. Paranhos-Baccalà, and G. Vernet (all Emerging 
Pathogens Laboratory, Fondation Mérieux, Lyon, France), J.-M. Crance (Virology 
Laboratory, Institut de Recherche Biomédicale des Armées [IRBA], Grenoble, France) 
and C. N. Peyrefitte (both institutions) presented Crimean-Congo Hemorrhagic Fever 
Virus Infects Human Hepatocytes and Induces Apoptosis and IL-8 Secretion. She 
began by explaining that the knowledge of Crimean-Congo hemorrhagic fever virus 
(CCHFV) pathogenesis is improving, as recently new target cells have been identified 
such as antigen presenting cells (Peyrefitte et al., 2010). Moreover, it has already been 
shown, that CCHFV causes liver damage in infected patients and in the animal model 
(Bereczky et al., 2010). The research objectives were to consider: (1) How does 
CCHFV affect hepatocarcinoma cell lines? (2) Is CCHFV able to enter and replicate 
into these cell lines? and (3) Does CCHFV modulate the in vitro cellular response? 
To better understand the CCHFV pathogenesis in liver cells, they analyzed in 
vitro the host response induced after CCHFV infection in Huh7 (unable to produce IFN-
Beta) and Hep-G2 (capable of producing IFN-Beta) cell lines. They noticed that while 
in Huh7, CCHFV infection elicited at day 3 a cytopathogenic effect, no visible effect 
was seen in CCHFV-infected HepG2. This intriguing feature led them to analyse the 
viral parameters expecting a differential cellular response. Both cell lines were shown to 
be permissive to CCHFV and with a high viral yield as monitored by plaque titration 
assay, genomic and anti-genomic strand quantification. These CCHFV- infected 
hepatocarcinoma cell lines induced only IL-8 secretion. In addition, a pro-apoptotic 
effect was observed in Huh7 but not in HepG2. Interestingly, no type-I IFN was 
detected for Hep-G2 during the kinetic study, suggesting a strong inhibition of IFN 
secretion. They concluded that CCHFV does enter and replicate in hepatocytes and that 
hepatocytes could be involved in CCHF pathogenesis associated with antigen 
presenting cells for CCHFV dissemination. While CCHFV did not induce IFN-Beta 
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secretion in hepatocyte cell lines, CCHFV did induce the secretion of IL-1 in hepatocyte 
cell lines. Furthermore, CCHFV induced a higher secretion of IL-8 in the apoptotic 
Huh7 cell line than in the nonapoptotic Hep-G2 cell line. Thus this research indicated 
that IL-8 production and apoptosis seemed to be markers of CCHFV pathogenesis in 
hepatocyte cell lines.  
 
Professor T. W. Geisbert (University of Texas, Medical Branch, Galveston, TX, USA) 
presented an Evaluation of Countermeasures against Hendra and Nipah Viruses in 
Nonhuman Primate Models. He pointed out that the henipaviruses, Hendra virus 
(HeV) and Nipah virus (NiV) are enigmatic emerging pathogens that can cause severe 
and often fatal neurologic and/or respiratory disease in both animals and humans. 
Guinea pigs, hamsters, ferrets, and cats have been evaluated as animal models of human 
HeV infection. A research team led by Professor Geisbert recently evaluated African 
green monkeys as a nonhuman primate model for henipavirus infection and discovered 
that they are the first consistent and highly susceptible nonhuman primate models of 
HeV and NiV infection (Geisbert et al., 2010; Rockx et al, 2010). The severe respiratory 
pathology, neurological disease and generalized vasculitis manifested in both HeV- and 
NiV-infected African green monkeys provides an accurate reflection of what is 
observed in henipavirus-infected humans. These nonhuman primate models were then 
employed to evaluate several post exposure treatments including ribavirin (which did 
not work) and a human anti-henipavirus monoclonal antibody (which was successful).  
 
Dr. M. Faber, with his colleagues B. Dietzschold, J. Li, D. Curtis and C. Arbuzzese (all 
Department of Microbiology and Immunology, Thomas Jefferson University, 
Philadelphia, PA, USA), B. Rockx and H and F. Feldmann (Laboratory of Virology, 
National Institute of Allergy and Infectious Diseases, Hamilton, MT, USA), H. 
Weingartl (National Centre for Foreign Animal Disease, Canadian Food Inspection 
Agency; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, 
Canada) and B. Horvat (INSERM, Lyon, France), considered the Nipah virus (NiV), a 
zoonotic paramyxovirus that can infect multiple species including humans, where it 
causes a lethal encephalopathy. Their research on A Single Immunization with Live-
Attenuated Recombinant Rabies Viruses Expressing the Nipah Recombinant 
Rabies Viruses Expressing the Nipah Virus (NiV) Glycoprotein Causes a Strong 
Anti-NiV Memory Response constructed live-attenuated recombinant rabies viruses 
(RVs) expressing the NiV G protein and tested them for their ability to trigger a primary 
or secondary virus-neutralizing antibody (VNA) response against NiV in mice.  
The research was motivated by the awareness that neutralizing antibodies are 
probably the major effectors against this viral infection. The rationale of using RV 
vectors for the development of a NiV vaccine was four-fold: (1) RV-vectored vaccines 
are not pathogenic regardless of the route of administration or the immune status of the 
host; (2) RV-based vaccines are very efficacious even after a single immunization by 
the oral route; (3) RV-based vaccines have the ability to target macrophages and 
dendritic cells, to induce TH1 T cell response and are capable of inducing long-lasting 
immunity; and (4) Post-exposure prophylaxis using recombinant RV vaccines is very 
effective, even when the CNS is already infected (Faber et al., 2009a; Faber et al., 
2009b). 
 The NiV G gene was inserted into the non-pathogenic RV vectors 
SPBAANGAS or SPBAANGAS-GAS, resulting in SPBAANGAS-NG or the 
double GAS variant SPBAANGAS-NG-GAS, respectively. Further research led to four 
significant conclusions: (1) There are no detectable amounts of NiV G present in 
recombinant NiVG-RV particles; (2) The presence of an NiV G gene does not increase, 
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but rather decreases the pathogenicity of the recombinant viruses; (3) Priming with 
NiVG-RV triggers a strong NiV G-specific memory response which correlates inversely 
with vaccine concentration used for the priming; and (4) a single immunization with 
NiVG-RV is probably sufficient to protect against a NiV challenge infection.  
 
Arenaviruses are rodent-borne bisegmented ambisense RNA viruses, which include 
Lassa fever virus, lymphocytic choriomeningitis (LCM) and Tacaribe viruses. Dr. E. 
Bergeron and his research team, A. K. Chakrabarti, C G. Albariño, L. K. McMullan, B. 
B. Bird, C. F. Spiropoulou and S. T. Nichol (all Viral Pathogens Branch, Centers for 
Disease Control and Prevention, Atlanta, GA, USA) and M. L. Khristova 
(Biotechnology Core Facility Branch, Centers for Disease Control and Prevention) 
presented the Reverse Genetic Generation of Lujo Virus, a Novel and Highly 
Pathogenic Arenavirus. The index case for this acute febrile illness virus was a travel 
agent living on a farm during 2008 in Lusaka, Zambia, who infected a local cleaner, as 
well as a paramedic and a nurse in Johannesburg, South Africa, all of whom died, with 
the paramedic infecting a further nurse who was treated with ribavirin and survived 
(Paweska et al, 2009). The name of the virus originated from the first two letters of the 
two key cities, LUsaka and JOhannesburg. Four of the five infected persons died of 
hemorrhagic fever-like symptoms (Paweska et al, 2009; Briese et al,2009) 
Viral genome sequencing revealed that this virus  differed from other 
arenaviruses by at least 36% and is highly pathogenic, with a case fatality rate (CFR) of 
80% (Paweska et al, 2009; Briese et al, 2009).  In view of the uniqueness and high 
virulence of Lujo virus (LJV), the research team developed a reverse genetics system to 
study the molecular characteristics of this novel arenavirus. This system will facilitate 
studies of LJV biology, development of antiviral screening assays and pathogenesis 
studies in animal models. 
 
T. Cutts (National Microbiology Laboratory, Public Health Agency of Canada, 
Canadian Science Centre for Human and Animal Health, Winnipeg, Manitoba, Canada) 
with his colleagues S. Theriault (Chief, Applied Biosafety Research Program, same 
Centre) and G. Kobinger (Chief, Special Pathogens Program, same Centre) presented 
Cytofix
TM
 Inactivation of VeroE6 Cells Infected with Zaire Ebola Virus (ZEBOV) 
both in vitro and in vivo. First, it was pointed out that removing infected tissues from 
high containment laboratories requires implementation of a number of different 
decontamination techniques to render the organism inert and is subject to flexibility 
according to the laws of the country in which the laboratory is located. According to the 
Canadian Biosafety Guidelines 4th edition, an organism may be removed from 
containment once it has been rendered inert, but no procedure is in place to validate 
these biosafety guidelines, and it is up to individuals to implement the relevant 
guidelines (Public Health Agency of Canada, 2004, p. 28. Chap. 3.1.4). Methods such 
as gamma irradiation, formalin fixation, acetone and methanol permeation, plus the use 
of various other chemical agents are common practices to preserve cellular tissue or 
blood components and to inactivate organisms (Villinger et al., 1999; Elliott et al., 
1982;  Mitchell and McCormick, 1984; Sanchez et al., 2007; Preuss et al., 1997).  Such 
methods still raise questions as to their effectiveness or their redundancy. Furthermore, 
these inactivation steps can lead to the alteration of the target organism possibly 
affecting the qualitative and quantitative results. The focus of the Applied Biosafety 
Research Program was to evaluate and develop technologies and procedures relevant to 
biocontainment in the context of the laboratory, as well as to prevent unintentional and 
intentional release of dangerous organisms into the environment. 
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Using the commercial product, Cytofix/Cytoperm
TM 
from BD Biosciences, this 
research sought to inactivate Vero E6 cells which had been infected with the deadly 
Zaire Ebola Virus (ZEBOV). The aim of the research was to determine the effectiveness 
and duration of Cytofix/Cytoperm for fixing the cellular material infected with ZEBOV. 
The VeroE6 cells were infected with the wild-type ZEBOV and a mouse adapted 
ZEBOV(MAZEBOV) and assayed after a 5 minute and 20 minute exposure to 
Cytofix™ followed by neutralization.  Samples of blood from a non human primate 
infected with ZEBOV were drawn at 7 dpi and assayed for effectiveness in the same 
manner as the in vitro studies with Cytofix™. In addition, Vero E6 cells infected with 
MAZEBOV were treated in the same manner and injected into BALB/c mice to 
compose the in vivo studies. Cytoxicity and neutralization assays were used to 
determine the effect (if any) the treatment had on both the virus and the health of host 
cells.  
Results of the tissue culture TCID50 assay showed that a 5 minute exposure to 
Cytofix™ inactivated a large portion of the cells containing infectious virions, while 
after a 20 minute exposure no detectable levels of virus were observed. Blood samples 
from the non-human primates showed similar results to the cell culture assay having no 
detectable virus from infected cells after 20 minutes of exposure. In vivo studies with 
mice showed that both a 5 minute and 20 minute exposure time to Cytofix™ had a 
100% survival rate after 28 days post infection while the positive controls succumbed 
after 4 to7 dpi. Because laboratories differ in their preferences of technique, the time of 
inactivation also varies. What this research demonstrated was the effectiveness of  a 
quick procedure of 20 minutes for inactivating viruses within cells infected with 
ZEBOV, thereby rendering organisms safe to remove from containment. 
 
The presentation at the Cancun Conference, Functional Analysis of the Ebola Virus 
Glycoprotein in Cell Lines from Potential Reservoir Bat Species  by A. Kühl, K. 
Grinβ, M. Kienne, T. S. Tsegaye (all Institute of Virology, Hanover Medical School, 
Hanover, Germany), M. Hoffmann and G. Herrler (Institute of Virology, University of 
Veterinary Medicine, Hanover), M. Müller and C. Drosten (Institute of Virology, 
University of Bonn Medical Center, Bonn, Germany) and S. Pöhlmann (Institute of 
Virology, Hanover and Department of Infection Biology, German Primate Center, 
Göttingen, Germany) has now been expanded and published in The Journal of 
Infectious Diseases (Kühl et al., 2011). Their focus was on how the EBOV-glycoprotein 
(EBOV-GP) facilitated viral entry and promoted viral release from human cells. They 
compared EBOV-GP interactions with human cells and cells from African fruit bats, 
leading to the finding that GP displayed similar biological properties in human and bat 
cells. The only exception was GP localization, which was to a greater extent 
intracellular in bat cells as compared to human cells. Collectively their results suggested 
that GP interactions with fruit bat and human cells are similar and do not limit EBOV 
tropism for certain bat species.    
 
The presentation by Dr. E. de Wit with her colleagues, V. J. Munster and H. Feldmann 
(all from the Laboratory of Virology, Division of Intramural Research, National 
Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, 
MT, USA) and S. Metwally (FAO Reference Center for Vesicular Diseases, US 
Department of Agriculture, Animal and Plant Health Inspection Service, Foreign 
Animal Disease Diagnostic Laboratory, National Veterinary Service Laboratories, Plum 
Island Animal Disease Center, Greenport, NY, USA), Assessment of Rodents as 
Animal Models for Reston Ebolavirus has now been revised and published in The 
Journal of Infectious Diseases (de Wit et al., 2011). Although Reston Ebolavirus 
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(REBOV) has not yet been linked with disease in humans, the presence of antibodies 
against REBOV in people working closely with infected macaques and swine indicates 
that humans can be infected with this virus (Miller et al., 1990; Miranda et al., 1991; 
Barrette et al., 2009). However, research has been hampered by the fact that the only 
available disease model for REBOV to date has been cynomolgus macaques. 
 Seeking new REBOV disease models, the research team assessed various rodent 
models—the Balb/c mouse, Hartley guinea pig, Syrian hamster and STAT1-/- mouse that 
lacked the signal transducer and activator of transcription 1 (Durbin et al., 1996). 
Although virus replication occurred in guinea pigs and hamsters, progression to disease 
was only observed upon inoculation of STAT1
-/-
 mice. Despite certain drawbacks set 
out in the journal article, the STAT1
-/-
 mouse can be used to investigate the determinants 
of differences in pathogenicity in various REBOV strains, as well as to assess 
vaccination and antiviral therapies (de Wit et al., 2011; Barrette et al., 2009; Durbin et 
al., 1996; Miranda et al., 1991; Miller et al., 1990).   
 
6. Emerging Bacterial Diseases 
The unity of human, animal and ecosystem health outlined by Professor Aguirre, as well 
as the interactions among multiple tick-borne pathogens in a natural reservoir host set 
out by Professor Fish and his research team, both summarized in Topic 1 above, 
highlight the necessity of cross-disciplinary collaboration in studying zoonotic bacterial 
diseases (Daszak et al., 2007, pp. 470-471). Such collaboration is especially important 
in studying tick-borne infectious disease, which emerged so extensively in the United 
States during the last three decades of the twentieth century (Paddock and Yabsley, 
2007, p. 290).  
Now, in an article published in this Special Supplement, Beyond Lyme: 
Etiology of Tick-Borne Human Disease with Emphasis on the Southeastern United 
States, Drs. Stomdahl and Hickling have explained that tick distributions are in flux, 
especially in the southeastern United States, requiring health providers to think ‘beyond 
Lyme’ in order to identify the specific tick species that bite humans and the different 
pathogens these ticks carry. In an international context, Drs. Wood and Artsob have set 
out the increasing importance of travel-associated rickettsioses in their article, Spotted 
Fever Group Rickettsiae: A Brief Review and a Canadian Perspective. In a third 
article published in this Special Supplement  Drs. Verma and Stevenson present an 
article on epidemiology of leptospirosis with its one million cases worldwide. In 
Leptospiral Uveitis – There’s More to It Than Meets the Eye! They hypothesize in 
detail about how the eye inflammation uveitis is triggered and stress the impact that 
‘understanding how this bacterium is able to induce this inflammatory process will be a 
key to the better management and prevention of the disease’. This continuum of basic 
research leading to understanding a disease and then to managing that disease and 
finally to preventing it offers a pattern of scientific discovery that is relevant to many 
other emerging zoonotic diseases. 
 
Supported by the work of eight collaborators, L. Joens (University of Arizona), C. 
Parker (US Dept of Agriculture), M. Hook (Texas A & M University) and D. Call, M. 
Hunzicker-Dunn, C. Kang, D. Shah and S. Simasko (all of Washington State 
University), as well as seven graduate students and post-docs, Professor M. E. Konkel 
(School of Molecular Biosciences, Washington State University, Pullman, Washington, 
USA) investigated the behaviour of Campylobacter jejuni. C. jejuni is one of the most 
common causes of bacterial gastroenteritis worldwide, causing some 400 to 500 million 
cases each year. Opening his presentation, The Foodborne Pathogen Campylobacter 
jejuni Exploits Mammalian Host Cell Receptors and Signaling Pathways, Professor 
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Konkel noted that the percent of C. jejuni isolates that are resistant to antibiotics is 
continuing to increase, and that C. jejuni infections are frequently associated with 
serious sequelae, including Guillain-Barré Syndrome. It is well understood that 
infection with C. jejuni is often a consequence of eating foods contaminated with 
undercooked poultry. However, C. jejuni pathogenesis is a highly complex process that 
is dependent on many factors including motility, adherence, cell invasion, protein 
secretion, intracellular survival, and toxin production. Acute illness, characterized by 
the presence of blood and leukocytes in stool samples, is specifically associated with C. 
jejuni invasion of intestinal epithelial cells. Dissecting bacteria-host cell interactions are 
critical to understanding the infection caused by C. jejuni. 
Previous work has shown that maximal invasion of host cells by C. jejuni is 
dependent on synthesis of the C. jejuni CadF and FlpA fibronectin (Fn) binding proteins 
and requires the secreted Campylobacter invasion antigens [Cia(s)] (Larson et al., 
2008). To test the hypothesis that maximal cell invasion requires specific signaling 
events, binding and internalization assays were performed in the presence of numerous 
inhibitors of cell signaling pathways. The research team found that C. jejuni cell 
invasion utilizes components of Focal Complexes (FCs), as invasion is significantly 
inhibited by wortmannin (an inhibitor of PI-3 kinase) and PP2 (a c-Src inhibitor). They 
further demonstrated that a wild-type strain of C. jejuni results in the activation of the 
Rho GTPase Rac1. These observations are consistent with the proposal that C. jejuni 
binding to host cell-associated Fn and secretion of the Cia proteins trigger integrin 
receptor activation, which in turn promotes intracellular signaling and actin cytoskeletal 
rearrangement. Based on these data, they concluded that C. jejuni utilizes a novel 
mechanism to promote host cell invasion. The research findings Professor Konkel 
presented were recently published in Cellular Microbiology (Eucker and Konkel, 2012). 
Simple, fast and specific tests for pathogen identification are essential for 
epidemiological investigation of numerous diseases. Within the field of 
immunodiagnostics, a quantitative determination of either antibody or antigen by 
antigen-antibody interaction can be made by lateral flow tests (also known as a dipstick 
or rapid tests). Dr. E. Baranova and her colleagues P. Solov’ev, N. Kolosova and S. 
Biketov (all State Research Center for Applied Microbiology, Obolensk, Russia) began 
the presentation, Development of Lateral Flow Tests for the Fast Identification of 
Zoonotic Disease Agents, by pointing out that lateral flow (LF) tests can be used in the 
field, as a diagnostic tool that produces results that can be read visually by the naked 
eye within 20 minutes after sample application. The creation of an algorithm for the 
development of an appropriate LF test to identify biopathogens requires the 
development of a target antigen, obtaining specific antibodies (Biketov et.al., 2010) and 
then creating a LF-test formulation to be trial tested. The target antigens must have the 
ability to induce species-specific antibodies, as well as be characterized by surface 
localization with multiple epitope presentation on the surface. The antibodies need to 
have a specificity and sensitivity sufficient for application in the LF detection format, as 
well as the capacity to be preserved after labelling with gold particles and after 
immobilization on a surface.  
Over a period of 22 months, the research team developed and tested in the field 
LF-tests for the detection of Bacillus anthracis which causes anthrax , Yersinia pestis 
which causes bubonic plague and Francisella tularensis which is the causative agent of 
tularaemia (or rabbit fever). All three of these LF-tests have now been made available as 
commercial products and are being used throughout Russia for the rapid identification 
of these dangerous pathogens. 
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Drs. J. D. Trujillo and P. L. Nara (Center for Advanced Host Defences, Immunobiotics 
and Translational Comparative Medicine, Iowa State University, Ames, Iowa, USA) 
have developed and validated a new approach to the diagnosis of infectious agents. Dr. 
Trujillo explained that they are employing novel Polymerase Chain Reaction (PCR) 
based methods for the detection and differentiation of current and emergent 
Mycoplasma species relevant to human and animal medicine and biodefense.  Their 
presentation, titled Novel SYBR
®
 Real-time PCR Assay for Detection and 
Differentiation of Mycoplasma Species in Biological Samples From Various Hosts, 
began by explaining the relevance of Mycoplasma species, which are endemic, strict or 
opportunistic pathogens in human and animal medicine. Moreover, Mycoplasma species 
are important re-emerging pathogens and foreign animal diseases. Importantly, 
Mycoplasma species are difficult to culture or are un-culturable, and thus are difficult to 
impossible to detect by conventional diagnostic methods. Moreover, current PCR 
methods have limited breath of species detection and differentiation, requiring the use 
of species specific assays which are costly and time consuming. Their goal was to 
develop a pilot Mycoplasma genus diagnostic assay to validate the novel application of 
High Resolution Melt (HRM) methodology for rapid, sensitive and cost effective 
detection and differentiation of various pathogenic mycoplasma species. 
Dr. Trujillo presented the validation and utilization of SYBR
®
 green dye in real-
time PCR (qPCR) Mycoplasma detection and differentiation assay (PanMYCO qPCR). 
This PCR assay utilizes primers specific for this genus (modified from S. C. Baird et al., 
1999). This PCR assay results in the generation of small DNA fragments of various 
base pair lengths called PCR amplicons. Each amplicon has a melt temperature (TM) 
that is determined following qPCR.  Sequence of amplicon representative of the 
Mycoplasma species present, defines the melt temperature (TM) and allows for the use 
of amplicons TM in species identification with limited resolution and excellent 
sensitivity. The PanMYCO qPCR assay has similar sensitivity to a conventional nested 
PCR assay for Mycoplasma bovis with a linear detection range of one colony forming 
unit (Trujillo et al, 2009). 
Additional work presented described increasing species resolution of this assay, 
by defining unique melt profiles for each Mycoplasma species amplicon utilizing 
Precision Melt software from Biorad, CA, USA to perform HRM analysis. Greater than 
30 different species of Mycoplasma found in bovine, caprine, ovine, avian and porcine 
hosts have been characterized with the PanMYCO qPCR and HRM analysis. 
Occasionally, this testing has resulted in the detection of multiple species in a single 
sample or discovery of novel or emergent Mycoplasma species. This data analysis 
method allows for the sensitive detection and rapid differentiation of numerous 
Mycoplasma species in many different hosts.  
Dr. Trujillo concluded that this novel real-time PCR assay can detect and 
potentially differentiate all known Mycoplasma species. Moreover, this presentation 
demonstrated the novel use of genus specific SYBR green PCR and HRM analysis for 
the detection, differentiation and discovery of medically important pathogens.  Several 
additional translational research projects have been launched to demonstrate the 
importance and utility of the PanMYCO qPCR assay in the context of infectious disease 
surveillance. One translational research project focuses on validation of this novel 
molecular methodology for field detection assays.  
 
7. Outbreak Responses to Zoonotic Diseases 
There is increasing awareness of the need for improved laboratory investigation, risk 
assessment, contingency planning and simulation exercises in order to respond 
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effectively to zoonotic diseases (Lipkin, 2008; Westergaard, 2008a and 2008b; Escorcia 
et al., 2012). In view of  the need to research into and respond to so many emerging 
zoonoses, it is relevant to note the four-fold classification of emerging zoonoses 
proposed earlier by Silvio Pitlik: Type 1: from wild animals to humans (Hanta); Type 
1+: from wild animals to humans, with further human-to-human transmission (AIDS); 
Type 2: from wild animals to domestic animals to humans (Avian flu); and Type 2+: 
from wild animals to domestic animals to humans, with further human-to-human 
transmission (SARS) (R. E. Kahn et al., p. 410, 2009). Confronting outbreaks of these 
emerging zoonoses is often possible with an imaginative combination of laboratory 
investigation and extensive fieldwork (Borchert et al., 2011; Robinson, 2011).  
Three distinctive articles appear below on outbreak responses to zoonotic 
diseases, highlighting the importance of linking together basic research, practical action 
and an integrated One Health-oriented approach. In Virus-like Particle-based 
Countermeasures against Rift Valley Fever Virus, Dr R. Koukuntla and his 
colleagues Dr. R. B. Mandell and Dr. R. Flick have outlined their pioneering work to 
create, develop and produce a virus-like particle (VLP)-based vaccine against Rift 
Valley fever virus (RVFV)—a dangerous arbovirus for which there is at present no US 
Food and Drug Administration (FDA) or US Department of Agriculture (USDA) 
approved vaccine. In Flexibility of Mobile Laboratory Unit in Support of Patient 
Management during the 2007 Ebola Zaire Outbreak in Democratic Republic of 
Congo, Dr. A. Grolla and nine co-authors from eight different institutions in five 
different countries have explained how two mobile laboratories were set up and capable 
of running within less than 24 hours of arrival, providing safe, accurate, rapid and 
reliable diagnostic services as the Ebola Zaire outbreak began in the Democratic 
Republic of the Congo. Finally, in Emerging and Exotic Zoonotic Disease 
Preparedness and Response in the United States: Coordination of the Animal 
Health Component, Dr. R. L. Levings has set out the integrated approach of 
Emergency Management and Diagnostics, Veterinary Services, Animal and Plant 
Health Inspection Service, United States Department of Agriculture in the prevention 
of, the preparedness for, the response to and the recovery from a zoonotic disease 
outbreak. In all three of these areas—basic research, practical action and an integrated 
One Health-oriented approach—much has been achieved in recent years, but much also 
remains to be achieved as soon as possible. Even when those diseases are not 
transmitted to humans there are substantive challenges, as highlighted in the next case 
study by Woods on combating brucellosis in cattle in Zimbabwe.   
 
In a practical, problem-oriented presentation, Dr. P. S. A. Woods (Veterinary Public 
Health Section, Faculty of Veterinary Science, University of  Pretoria, Onderstepoort, 
South Africa and University of Reading) with  R. S. Beardsley (Pharmaceutical Health 
Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland, 
USA) and N. M. Taylor (Veterinary Epidemiology and Economics Unit, School of 
Agriculture, Policy and Development, University of Reading, Reading, United 
Kingdom)  asked Can We Increase Farmers’ Perception of Their Brucellosis 
Susceptibility to Improve Adoption of Preventive Behaviors Amongst Small-Scale 
Dairy Farmers in Zimbabwe? She explained the background to the problem, 
presented a model that was used to develop a strategy to confront the disease, and then 
set out the results and recommendations of the research team. 
Brucellosis is an extremely infectious bacterium which causes abortion in cows, 
different syndromes in other animal species and malaria-like undulant fever, arthritis, 
depression and epididymitis in people. However, it had been controlled in Zimbabwe 
until 2001 when financial constraints forced the government veterinary services to 
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curtail disease surveillance and discontinue free vaccinations. Small-scale farmers did 
not seek vaccination from other sources, partly because they were unaware of the 
necessity of vaccination; and also at that time brucellosis was absent from small-scale 
farming areas. However, uncontrolled cattle movements from 2000 to 2009 linked to 
invasions of large-scale farms resulted in dispersal of possibly brucella-positive cattle 
and movement of the disease into small-scale herds. The result was that brucellosis 
became a potential problem in these herds and now presents a serious zoonotic threat. 
Preventing brucellosis requires movement control to stop brucella-positive cattle 
entering an area, as well as live vaccine for female calves. Although there is no human 
to human spread of the disease, it is essential that people do not handle new-born calves 
or abortions from brucella-positive cows, nor drink unpasteurized milk from brucella-
positive cows (Arimi et al., 2005). In essence, reducing the risk of brucellosis requires 
that farmers adopt appropriate preventive behaviors, with these control efforts and 
changes in behavior being community-directed in order to be sustainable. It was this 
stress upon community direction that formed the basis for funding by the Wellcome 
Trust to investigate the hypothesis that the level of a farmer’s knowledge about 
brucellosis would influence subsequent preventive behaviour. The approach, based 
partly on  the ‘Health Belief Model’ (Rosenstock et al., 1988) was grounded in the 
expectation that each small-scale farmer would make health behavior choices according 
to individual perceptions about the disease and personal beliefs about their abilities and 
the costs required to change the risks of their cattle and families acquiring the disease. 
In this project the independent variable was the level of an individual farmer’s 
knowledge about brucellosis, while the dependent variables were two key preventive 
behaviors—decreasing cattle disease by calfhood vaccination and preventing zoonotic 
disease by milk pasteurization.  
 The research was carried out in partnership with a national network of small-
scale dairy cooperatives with all activities conducted with existing local personnel. The 
aim was to tailor the educational program to the initial knowledge or awareness of each 
community of farmers, recognizing the considerable difference in knowledge levels 
between and within communities. Local teams, not outsiders, developed appropriate 
educational materials, targeting those with the lowest levels of knowledge. Completed 
survey questionnaires indicated a significant relationship between the initial level of 
farmers’ knowledge about brucellosis and their calf brucellosis vaccination practices.  
The range of brucellosis knowledge among some 210 small-scale farmers in Southern 
Zimbabwe was considerable, with 38 percent of farmers being unaware of the disease, 
12 percent having limited knowledge and 50 per cent having good knowledge. 
However, even amongst those farmers with a relatively high level of knowledge, 78 per 
cent of farmers had not vaccinated their calves at the time of the survey.  Furthermore, 
there was a disappointingly low uptake of milk boiling despite a significant increase in 
knowledge about raw milk as a mode of infection for humans. Although the information 
sessions did increase farmers’ awareness of the dangers of zoonotic brucellosis, an 
exaggerated perception of the effectiveness of calf vaccination decreased the likelihood 
of safe milk practices. This outcome indicated the importance of reaching the women 
who were responsible for milk and food preparation. 
 Ongoing research is investigating if increasing the role of nurses and 
environmental health technicians to emphasize human infection and to reach different 
family members, within a research paradigm which combined veterinary and human 
medicine would increase the uptake of milk hygiene practices. 
 
8. Food-borne Zoonotic Diseases 
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There is increasing awareness of the need to balance transparency with carefully 
designed information disclosure strategies in the face of sudden outbreaks of food-borne 
diseases (National Research Council, 2011; Taylor, 2011). Both consumers and 
producers must be rapidly informed of any significant dangers with specific food 
products; however, considerable misinformation can be spread if laboratory results are 
incomplete or inconclusive (Palm et al., 2012). Recent experience with E.coli-infected 
sprouts in Germany and listeria-infected cantaloupes the United States has highlighted 
the difficulties in identifying the original source of a disease outbreak, as well as the 
swiftness with which an unexpected food-borne disease can cause sickness and death 
(Blaser, 2011; Buchholz et al., 2011; Frank et al, 2011; Armour, 2011). It should be 
noted that that there was no easily identified zoonotic link in either of these two food-
borne diseases derived from bacteria, which killed 29 people in the United States and 50 
throughout Europe during 2011; however, as Professor C. Kastner points out below, a 
significant number of these food-borne diseases do have a zoonotic origin (Parker et al., 
2011). 
 Two articles linked to this topic are published in this Special Supplement. First, 
there is Emerging Antimicrobial Resistance in Commensal E. Coli with Public 
Health Relevance by  Dr. A. Käsbohrer and her colleagues. Their aim was to assess the 
prevalence of and trends in antimicrobial resistance through active monitoring programs 
along the food production chains for poultry, pigs and cattle, as well as to collect 
isolates for resistance testing and then select certain isolates for further phenotypic and 
genotypic characterisation. The research team found alarming rates of resistance to 
antimicrobials in zoonotic bacteria and commensals, as set out in their article, which 
could compromise the effective treatment of human infections. This work provides a 
basis on which to improve both risk assessment and risk mitigation strategies in the face 
of the increasing antimicrobial resistance to zoonotic bacteria and parasitic organisms 
within both humans and animals. Second, in American Trypanosomiasis Infection in 
Fattening Pigs from the South-East of Mexico, M. Jiménz-Coello and her colleagues 
have investigated the extent to which the protozoa Trypanosoma cruzi (T. cruzi) is 
presenting in fattening pigs in Yucatan, Mexico, threatening parasitic infections in 
animals destined for human consumption.  
 
Tackling the question of how to refine national and international strategies to combat 
food-borne zoonotic diseases, Professor C. Kastner (Food Science Institute, Kansas 
State University, Manhattan, Kansas, USA) considered the public health and economic 
impact of Food-borne Zoonotic Diseases. He began by noting that each year in the 
United States, according to statistics from the Centers for Disease Control, 48 million 
people become sick from food-borne diseases, 128,000 are hospitalised, and 3,000 die. 
A significant portion of these diseases have a zoonotic origin, with extensive product 
recalls and domestic as well as international trade disruptions (Fung et al., 2001). 
Therefore, more than 20 years ago the US Department of Agriculture established a Food 
Safety Consortium (2011) which focuses on food-borne zoonotic diseases involving 
beef in Kansas, pork in Iowa and poultry in Arkansas. The continuing aim of that 
consortium is to develop long-term control strategies which identify the critical control 
points and control technologies, as well as short-term strategies to address incidental 
contamination, whether accidental or intentional. 
 The US livestock industry in general and Kansas in particular are vulnerable to 
food-borne zoonotic diseases. For example, in Kansas, sources of contamination include 
feed, feedlots (which vary in size from 1,000 to 150,000 head per lot) and packing 
plants (which vary in size from 3,000 to more than 5,000 head per day per plant). Beef 
processing points where mixing of different ingredients occurs are the most critical 
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points for both incidental and intentional contamination. In the light of these challenges, 
a Biosafety Level 3 research facility, the Biosecurity Research Institute (2011) has been 
built on the Kansas State University campus, to evaluate strategies to detect and control 
food-borne zoonotic diseases from production through processing.  
Furthermore, in Minneapolis, Minnesota, NCFPD (National Center for Food  
Production Defense, 2011) has been operational since 2004 as a Department of 
Homeland Security Center of Excellence. NCFPD has adopted a systems approach 
whose goals include to: (1) ensure significant improvements in supply chain security, 
preparedness and resiliency; (2) develop rapid and accurate methods to detect incidents 
of contamination and to identify the specific agent(s) involved; (3) apply strategies to 
reduce the risk of food-borne illness due to intentional contamination in the food supply 
chain and to develop the tools to facilitate recovery from contamination incidents; (4) 
deliver appropriate and credible risk communication messages to the public; and (5) 
develop and deliver high-quality education and training programs to develop a cadre of 
professionals equipped to deal with future threats to the food system. These research 
centers are essential to minimize the threat of food-borne zoonotic diseases. 
 
T. Cutts (National Microbiology Laboratory, Public Health Agency of Canada, 
Canadian Science Centre for Human and Animal Health, Winnipeg, Manitoba, Canada)  
presented Comparative Inactivation Studies of Listeria Monocytogenes at Room and 
Refrigeration Temperatures on behalf of a research team which included B. 
Carruthers, C.-L. Cross, S. Theriault (Chief, Applied Biosafety Research Program, same 
center) and himself. Listeria monocytogenes, a non-sporulating, gram-positive bacillus, 
is found chiefly in ruminants, but can affect all species and causes listeriosis, an 
infrequent but serious illness that affects the central nervous system of humans and 
domestic animals (Bortolussi, 2008; Chan and Weidmann, 2009). Listeriosis can be 
acquired from the consumption of contaminated foods and has an incubation period 
ranging from 2 to 70 days (Bortolussi, 2008; Chan and Weidmann, 2009). Because of 
this variable incubation period and the fact that listeriosis leads to a mortality rate of 20 
to 30 percent, the Applied Biosafety Research Program at the National Microbiology 
Laboratory of The Public Health Agency of Canada considered the significance of 
proper decontamination of listeria in food processing environments (Chan and 
Weidmann, 2009). The importance of this work is indicated by the fact that somewhere 
from 1 to 10 percent of ready-to-eat foods are thought to be contaminated with listeria 
(Health Canada, 2004). 
Recently, Listeria monocytogenes has gained notoriety because of its ability to 
grow at the low temperatures, high salt and low pH used in food processing plants 
(Bortolussi, 2008). Therefore, a study was undertaken to determine the bactericidal 
efficacy of various liquid disinfectants and the effect that low temperatures have on the 
ability of these disinfectants to inactivate L. monocytogenes at conditions found in food 
processing plants. 
At both room and refrigeration temperature (40), ethanol, Javex, SU393 and 
Peracetic acid (PAA) products outperformed all others. Surprisingly, there was no 
significant variation in performance at room temperature compared with refrigeration 
temperature. However, since some organisms undergo changes during a temperature 
shift, it is crucial to test each disinfectant at the temperature at which it will be 
employed. Bleach was found to be effective but is toxic, corrosive and residue forming, 
while the PAA and ethanol compounds do not form residues and are not corrosive. As a 
result of these studies major Canadian food processing plants have changed their 
decontamination procedures and are no longer using Quaternary Ammonium 
Compounds (Quats), which were previously used extensively. Positive relations have 
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been built up between companies and laboratories, leading to more relevant laboratory 
studies and industrial applications (Public Health Agency of Canada, 2012). 
 
9. Prion Diseases 
A prion (proteinaceous infectious particle) has been defined as a ‘malformed version of 
a normal cellular protein which apparently “replicates” by recruiting normal proteins to 
adopt its form, [thus becoming] capable of infecting other cells of the same, or a 
different organism’ (Thain and Hickman, 2004, p. 573; Prusiner, 2003). Although two 
Nobel Prizes in Medicine have been awarded for prion research, to Carleton Gajusek in 
1966 and to Stanley Prusiner in 1997, the precise nature of the infectious agent remains 
unclear to such an extent that controversy continues about whether a prion is solely 
protein (Brooks, 2011, pp. 75-100). Whatever the cause, prion diseases are fatal chronic 
neurological diseases that affect the brains and nervous systems of many mammals, 
including humans (Imran and Mahmood, 2011).   
Prions can be detected in tissues by a number of research techniques, including 
infective bioassay, animal inoculation, Western blot and immunochemistry. It is clear 
that prions can cause spongiform encephalopathies within both humans and animals 
(e.g. Creutzfeldt-Jakob disease, kuru, scrapie, transmissible mink encephalopathy, feline 
spongiform encephalopathy, and bovine spongiform encephalopathy) (Blood et al., 
2007, p. 1456). Summaries of the three presentations below offer further insights into 
the nature of prion diseases. 
 
In Prion Diseases, Professor J. J. Badiola and Dr. C. Akin (University of Zaragoza, 
Zaragoza, Spain) focused on the 1986 outbreak of bovine spongiform encephalopathy 
(BSE) (“mad cow disease”) in the United Kingdom, which led to a better understanding 
of the epidemiology and molecular characteristics of the disease. Epidemic BSE 
affected mainly the United Kingdom, with a total of 184,615 positive animals compared 
to 5,765 in all other member states of the European Union (OIE, 2012). Control and 
eradication of Transmissible spongiform encephalopathies (TSEs) became a priority, 
not only in Europe, but throughout the world. 
 In 2000, a reinforcement of the passive surveillance program and the 
establishment of an active one were established by the European Commission for all the 
European Union member states (European Commission, 2001). Passive surveillance, 
focused on animals with clinical signs of the disease, and active surveillance was carried 
out in the following target groups: healthy slaughtered; fallen stock; emergency 
slaughtered; and animals culled under BSE eradication. Apart from these measures, 
specific risk materials (e.g. tonsils, intestines, spleen, spinal cord and skull, including 
the brain and eyes) were defined and prohibited from being included in the human food 
chain. Moreover, a banning of all meat and bone meal for animal feed was established 
(European Commission, 2009).  
The result of these powerful eradication measures has been a rapidly decreasing 
number of new BSE cases, with less than 50 cases detected worldwide in 2010, 45 of 
which were in the European Union (OIE, 2012). The impressive containment of BSE in 
the United Kingdom from 35,090 reported cases in 1993 to 11 in 2010 is testimony to 
the determination with which scientists, politicians, civil servants and farmers have 
worked together to bring the disease under control. 
 
Professor C. I. Lasmézas (Dept of Infectology, The Scripps Research Institute, Scripps, 
Florida, USA) began her presentation, Zoonotic Potential of New Animal Prion 
Diseases: Assessment in Non-Human Primates, by noting that the first demonstration 
of the transmissibility of a prion disease to Non-Human Primates (NHPs) was made in 
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1966 by Carleton Gajdusek when he transmitted kuru to chimpanzees. Since then, 
animal and human prion diseases have been transmitted to a range of NHPs. 
Cynomolgus macaques have shown the highest selectivity with regards to the prion 
strain by which they can be infected and therefore seem to be the species of choice to 
assess the risk that any given animal prion strain can infectibe pathogenic for humans 
(Lasmézas, 1996).  
 Prions were thought to be very difficult to transmit from one species to another; 
however, the experience of studying scrapie highlights the difficulties inherent in 
studying prion diseases in the lab. Scrapie had been transmitted orally to other 
ruminants (goats) but only intracerebral inoculations had successfully transmitted 
scrapie to monkey, mouse or mink. However, the oral transmission of bovine 
spongiform encephalopathy (BSE) to domestic cats in 1990 forced a revision of this 
earlier belief. Transmissions of BSE have now occurred orally to sheep, goat, monkey, 
mink, cheetah, puma, cat and mouse. Intracerebral transmission of BSE has also 
occurred to pig. Furthermore, intraspecies oral transmission of BSE has taken place 
within numerous species— monkey, mink, sheep, goat, cow, hamster and mouse. vCJD 
(variant Creutzfeldt-Jakob Disease) is a new human disease, which was caused by 
eating ruminant-derived food products contaminated with BSE. vCJD poses a public 
health problem because of the absence of preclinical diagnostic test, the long incubation 
periods of prion diseases in humans (possibly extending up to 50 years) and the 
transmissibility of the disease by blood transfusion. 
The research team at the French Commissariat a l’Energie Atomique (CEA) 
demonstrated that bovine spongiform encephalopathy (BSE) was transmissible to 
macaques within 3 years with a 100% infection rate and caused a disease 
indistinguishable from the human variant of Creutzfeldt-Jakob disease (Lasmézas et al., 
1996). This provided a model to study carefully the peripheral pathogenesis of vCJD, 
the oral infectious dose of BSE, and evaluate the risk of human-to-human transmission 
of vCJD by blood transfusion (Herzog et al., 2004). Further, the research team used the 
macaque model to assess the zoonotic potential of emerging forms of BSE called L-or 
H-type. The L-type BSE presents with higher pathogenicity to macaques than classical 
BSE (Comoy et al, 2008). Therefore, continued precautionary measures remain 
necessary to protect the human food chain. Experiments are ongoing at the National 
Institute of Allergy and Infectious Disease, Hamilton, Montana, to assess the risk linked 
to chronic wasting disease that is spreading throughout the USA. The closing 
acknowledgements of Professor Lasmézas to 35 other researchers indicated both the 
complexity and importance of continuing work in prion diseases. Furthermore, since the 
Cancun Meeting further important research has been published (Hamir et al, 2011).  
 
Infectivity distribution studies of animals infected with BSE prions animals are a matter 
of considerable importance in seeking to elucidate the route of infectious prions from 
the gut to the central nervous system (CNS) in preclinical infected animals. Prof M. H. 
Groschup and his colleagues, A. Balkema-Buschmann, M. Kaatz, U. Ziegler and C. 
Hoffmann (all Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-
Institut, Greifswald-Insel Riems, Germany) along with A. Oelschlegel (Scripps Institute 
Florida, Jupiter, Florida, USA) and L. McIntyre (University of Calgary, Calgary, 
Canada) investigated the Early Spread of BSE Prions from the Gut via the 
Peripheral Nervous System to the Brain. There are a number of open questions about 
this lethal journey from the gut to the brain, including where in the gut the disease 
begins, the initial steps of the neuronal BSE pathogenesis, the ascension of BSE prions 
to the brain, the haematogenous spread and the centrifugal contamination of the 
periphery (Buschmann and Groschup, 2005; Hoffmann et al., 2007). The scale of the 
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research task was indicated by the fact that 1400 samples were collected from  per 
animal autopsy, leading to some 200,000 frozen samples collected and archived at the 
Friedrich-Loeffler-Institut. 
 Tissue samples were collected from the gut, the central and autonomous nervous 
system (ANS) of the challenged bovines and then examined for the presence of 
pathological prion proteins (PrP
Sc
). There was some variation among different animals. 
However, a distinct accumulation of PrP
Sc
 was observed in the distal ileum, confined to 
follicles and/or the enteric nervous system, in almost all animals (Hoffmann et al., 
2011). BSE prions were found in the sympathetic nervous system starting from 16 
months post inoculation (mpi) on as well as in the parasympathetic nervous system from 
20 mpi on (Kaatz et al., 2012). A clear dissociation of prion infectivity and detectable 
PrP
Sc
 deposition was obvious in tongue (Balkema-Buschmann et. al., 2011). The earliest 
presence of infectivity in the brainstem was detected at 24 mpi, while PrP
Sc
-
accumulation was detected first after 28 mpi. In summary, these results deciphered for 
the first time the centripetal spread of BSE prions along the ANS to the CNS starting 
already half way during the incubation period. BSE prions spread in cattle from the gut 
to the brain along the sympathetic, parasympathetic and spinal cord routes, possibly in 
that order of importance. Spinal cord involvement may even not be necessary at all, but 
BSE infectivity in the form of PrP
Sc
 spills over into the periphery already in the pre-
clinical phase.  
 
10. Modeling and Prediction of Emergence of Zoonoses 
The modeling and prediction of emerging zoonoses is a fast growing field of 
considerable complexity. Of the five papers relevant to this topic, two have been 
published in full below in this Special Supplement. Dr. G. Zanella and her colleagues 
consider Modelling Transmission of Bovine Tuberculosis in Red Deer and Wild 
Boar in Normandy, France. Their mathematical model of the Mycobacterium bovis 
infection within and between species takes into account the transmission of M. bovis 
through infected offal—the viscera of animals killed by hunters and left behind. When 
an animal was hunted in the Brotonne Forest in Normandy prior to 2002 it was 
eviscerated in situ and only the carcass taken away, with the raw viscera left behind. 
Since 2002, offal disposal has been required in Brotonne forest ; however, the 
regulation has not always been observed by hunters  (Unpublished correspondence with 
G. Zanella, December 16-17, 2011)   An important benefit of mathematical modelling is 
that it permits consideration of all the elements involved in disease transmission within 
a population, thereby complementing field data, as well as testing the effects of control 
measures. Thus the direct transmission of the M. bovis infection within the red deer and 
wild boar populations can be distinguished from indirect transmission through 
contaminated offal. The model indicates that offal destruction is the key factor in 
infection control for both red deer and wild boar. The authors conclude that, in 
principle, the structure of this model is relevant to situations where dead animals play an 
important role in disease transmission between two or more species.  
 
In a further article published in this Special Supplement, Constructing Ecological 
Networks: A Tool to Infer Risk of Transmission and Dispersal of Leishmaniasis, 
Dr. C. González-Salazar and Professor C. Stephens set out the role of ecological 
networks as a powerful tool for understanding and visualizing inter-species ecological 
and evolutionary interactions. Taking the example of leishmaniasis in Mexico, they 
show that such networks can be used not only to understand potential ecological 
interactions between species involved in the transmission of the disease, but also to 
identify the potential role of the environment in disease transmission and dispersal. 
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Strikingly, they show how potential interactions can be inferred from geographic data, 
rather than by direct observation. Their findings have led to the prediction of additional 
reservoirs in Mexico of many new species, including bats and squirrels. The resulting 
model can be used to understand and map potential transmission risk, as well as 
construct risk scenarios for the dispersal of leishmaniasis from one geographic region to 
another. Such a risk assessment tool for leishmaniasis will be especially useful in the 
light of the Bill and Melinda Gates Foundation decision in January 2012 to join with 13 
major pharmaceutical companies and the World Health Organization in targeting 
leishmaniasis as one of the neglected tropical diseases to receive improved drugs, 
diagnostics, vector control strategies and vaccines (Bill and Melinda Gates Foundation, 
2012; Boseley, 2012). However, the possibility of new reservoirs suggests it is hard to 
imagine that Leishmaniasis can be completely eradicated. Nevertheless, it is 
increasingly clear that leishmaniasis has a disturbing capacity to jump from species to 
species, so efforts to control the disease must be given a high priority (Unpublished 
correspondence with C. Stephens, February 1, 2012; cf. Flanagan et al, 2011). 
 
It is difficult to model and predict the distribution and impact of a new emerging virus. 
For example, the emergence in November 2011 in Europe of a midge-borne virus 
member of the Bunyaviridae family, named Schmallenberg virus after the location in 
Germany where it was first detected, has caused serious birth defects in lambs, goats 
and cattle (ECDPC, 2011). Scientists, farmers, veterinarians, public health officials and 
consumers are all confronted with the uncertainty inherent in facing a new animal 
pathogen (Farmers Weekly, 2012). Appropriately, at the same time as this new virus has 
emerged, the Animal Health and Veterinary Laboratories Agency (AHVLA) has set up 
a new independent advisory group to evaluate veterinary surveillance in England and 
Wales, although their original intent was in part to consider funding reductions  
(Trickett, 2012). 
 
Modeling risk factors for zoonotic influenza infections is challenging because 
the infections are often rare; the laboratory assays are often difficult and 
imprecise; and the most definitive studies require intensive resources. This was the view 
of Professor G. C. Gray (Emerging Pathogens Institute and College of Public Health 
and Health Professions, University of Florida, Gainesville, Florida, USA) in his 
presentation, Modeling Risk Factors for Zoonotic Influenza Infections in Man: 
Challenges and Strategies for Success. In particular, serologic detections of these 
infections in humans may be confounded by cross-reacting antibody, waning antibody 
from the infection of interest, inaccurate matching of the enzootic pathogen and the 
laboratory strain, laboratory errors, and weakly powered statistical comparisons.  
 The underlying question which Professor Gray and his research team is tackling 
is: Which human, animal and environmental factors predict disease? These three factors 
can be viewed as a Venn diagram with its intricate interactions. Like understanding 
cardiovascular disease, how a person acquires a zoonotic influenza infection is a 
complex process, and predictive laboratory assays are imprecise. For example, with 
avian influenza viruses (especially H5N1, popularly known as ‘Bird Flu’), poultry 
veterinarians, turkey workers, hunters and people without indoor plumbing may be at 
increased risk of AIV infection but infections are rare. Subclinical or mild infections do 
occur; and occasionally AIV causes severe disease in persons exposed to sick birds. 
Although AIV transmission from human-to-human seems rare, further cohort studies 
and more sensitive serological assays are needed.  
A basic scientist often tests hypotheses by: (1) carefully setting up an 
experimental setting; (2) isolating confounding factors; and (3) looking for statistically 
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significant associations with an outcome.  Such a process is not possible for a number of 
emerging disease problems such as human infections with swine influenza virus (SIV).  
Experimental studies are not possible.  Hence, epidemiologists must perform 
observational studies of people most likely to be infected with SIV and by looking at 
possible risk factor associations, infer causality.  One must first determine settings 
where the prevalence of SIV in expected to be high and then study those workers.  For 
example, SIVs are often endemic in large-scale modern production facilities. Risk 
factors for sow-herd SIV seropositivity involve pig density, whether there is an external 
source of breeding pigs, the total animals on the site and the closeness of barns. 
Similarly, risks factors for finisher-herd SIV positivity must be considered—the number 
of SIV positive sows, size of herd, pig farm density and farrow-to-finish type of farm 
(Poljak et al., 2008). However, SIV surveillance in pigs is largely passive and voluntary, 
so recognizing which pig workers to study is a challenge.  Detection of SIV infections 
in man often requires a sentinel event (e.g. human illness with pig exposure or sick 
pigs).  As pigs do not always have clinical signs of novel virus infection; and often there 
is no compensation system to protect pig farmers, the pork industry is reluctant to 
permit the study of their workers for SIV infection (Gray and Baker, 2011). Therefore, 
these observational studies are currently very difficult. 
 Professor Gray concluded by pointing out that although there are numerous 
challenges in conducting epidemiological studies for zoonotic influenza, there are six 
substantive ways to control confounding variables: (1) design every study carefully; (2) 
use non-animal-exposed controls; (3) employ validated laboratory assay using zoonotic 
influenza strains; (4) use multivariate modeling to examine cross-reacting serologic 
responses due to human viruses and vaccines; (5) consider proportional odds modeling; 
and (6) consider employing a second unique serologic test (See GPL, 2012).  
 
With the support of 26 co-authors from 21 different institutions, Dr. K. J. Linthicum 
(United States Department of Agriculture, Agricultural Research Service, Center for 
Medical, Agricultural & Veterinary Entomology, Gainesville, FL, USA) presented two 
case studies about Forecasting Emerging Vector-Borne Diseases. Dr. Linthicum 
began by pointing out that global climate variability, often linked to El Niño conditions, 
can be used to forecast emerging vector-borne disease spread in local areas (Linthicum 
et al., 1999). These forecasts are possible because specific pathogens, their vectors, and 
hosts are sensitive to temperature, moisture, and other ambient environmental 
conditions. With consistent and reliable satellite observations, global sea temperatures, 
climate and vegetation can be observed. 
 First, temperature plays a major role in its impact on Aides aegypti mosquitoes 
transmitting dengue hemorrhagic fever virus in Southeast Asia (Linthicum et al., 2008) 
and possibly also on how Ae. aegypti transmits chikungunya virus in Africa and Asia 
(Anyamba et al., 2012), as well as on how Anopheles species mosquitoes transmit P. 
vivax malaria in the Republic of Korea. Vectorial competence is dependent upon the 
Extrinsic Incubation (EI) period in the mosquito vector. The EI represents the time from 
ingestion of the virus while feeding on a viremic host to the virus arriving in the 
salivary glands. The shorter the EI period, which occurs during higher ambient 
temperatures, the greater the vectorial competence (Garrett-Jones and Shidrawi, 1969). 
If data are available for a specific local area on the daily human-biting rate (ha) of the 
mosquitoes, the daily rate of blood feeding (a) and the length of the EI cycle (n), it is 
possible to calculate vectorial capacity (Rattanarithikul et al., 1996).  
Second, accurate measurements and understanding of how exceptionally heavy 
rainfall and flooding affects Aides and Culex mosquitoes and the introduction of virus 
infected mosquitoes into susceptible vertebrate hosts enables forecasts to be made about 
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when and where Rift Valley fever (RVF) will develop in sub-Saharan Africa and 
Middle East (Anyamba et al., 2009). Outbreaks of Rift Valley Fever are known to 
follow periods of widespread and heavy rainfall associated with the development of a 
strong inter-tropical convergence zone over Eastern Africa (Davies et al., 1985). During 
periods of elevated transmission there is a significantly increased risk of globalization 
of these and other arboviruses; however, the forecasting methods described provide 2.5 
to 5 months early warning before an outbreak and provide ample time for disease 
mitigation before the first cases appear  (Anyamba et al., 2010).  
Furthermore, the emergence and expansion of a number of disease vectors (e .g. 
mosquitoes, mice, locust) often follow the trajectory of the green flush of vegetation in 
semi-arid lands. The ability to predict periods of elevated risk enables better prevention, 
containment, or exclusion strategies to be drawn up to limit globalization of emerging 
pathogens. Thus it has been possible for the Food & Agricultural Organization (FAO) to 
create a system of alerts—the Emergency Prevention System for Transboundary Animal 
and Plant Pests and Diseases (EMPRES, 2012).  
Subsequent to Dr Lithicum’s presentation, significant further work has been 
done to provide a genome-scale overview of gene expression in the malaria-transmitting 
mosquito Anopheles gambiae (McCallum et al, 2011), as well as to expand the 
VectorBase website with regularly updated genome information on two other mosquito 
species, Aedes aegypti and Culex quinquefasciatus and numerous other organisms, 
including the tick species Ixodes scapularis (Lawson et al, 2009; NIAID, 2012). The 
ultimate aim of this research is to create a database that will facilitate a systems-level 
view of gene expression for many different organisms. 
 
Reflecting on the numerous types of statistical analysis that are used to estimate 
confidence intervals for proportions in scientific studies, Dr. S. Guillossou and his 
colleagues Professors H. M. Scott and J. A. Richt (Dept. of Diagnostic Medicine and 
Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, 
Kansas, USA) utilized the final presentation of the conference, Estimates of Low 
Prevalences and Diagnostic Test Estimates: What Confidence Do We Really Have? 
to illustrate the differences, limits and sometimes chaotic behavior of different statistical 
approaches. Dr. Guillossou pointed out that there were more than 15 different methods 
for determining a 95 percent confidence interval of a proportion. He stressed that it is 
always important to report the method of statistical analysis being utilized. In his view, 
the Agresti-Coull interval approach presents a satisfactory compromise between 
computational requirements and coverage probability (Newcombe, 1998; Brown et al, 
2001). Ideally, the effects of coverage probability should be estimated and the most 
appropriate method chosen before reporting the findings or using proportions as inputs 
in any epidemiological study.  
 
Conclusion 
 What did this 6
th
 International Conference on Emerging Zoonoses achieve? 
There was the opportunity to meet old friends and make new friends, to share one’s 
academic work and to reflect on what lies ahead with emerging zoonoses. It is now clear 
that human medicine, veterinary medicine and environmental challenges are a unity 
which must be considered under the umbrella of ‘One Health’ (One Health Initiative, 
2012).  
Viruses are continuing to jump from animals to people with unexpected 
consequences, because the evolution of any virus is impossible to predict. Even the 
recent relatively mild swine flu virus infected 10 percent of the human population and 
killed some 100,000 people globally—far less than would have been the case if the 
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virus had mutated to a more deadly form, as might easily have happened. The reality is, 
as Professor Nathan Wolfe, Professor in Human Biology at Stanford University, has 
commented: ‘As a species, we’re not that focused on the things that have the most 
potential to be devastating to us as a global population, such as viruses. Unless people 
take these things seriously, we’re going to look back and say we had all the tools 
necessary to try to address these risks, and we basically ignored them because they 
weren’t dramatic like a car accident or a hurricane’ (Geddes, 2011; Wolfe, 2011; L. H. 
Kahn, 2011). This conference, many others and the 7th International Conference on 
Emerging Zoonoses to be held in 2014 in Berlin are aimed at creating, improving and 
using the tools essential to address the risks of viral contagions in a global society. 
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